<SEC-DOCUMENT>0001437749-23-010408.txt : 20230417
<SEC-HEADER>0001437749-23-010408.hdr.sgml : 20230417
<ACCEPTANCE-DATETIME>20230417143016
ACCESSION NUMBER:		0001437749-23-010408
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		22
CONFORMED PERIOD OF REPORT:	20230413
ITEM INFORMATION:		Entry into a Material Definitive Agreement
ITEM INFORMATION:		Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
ITEM INFORMATION:		Regulation FD Disclosure
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20230417
DATE AS OF CHANGE:		20230417

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			ICAD INC
		CENTRAL INDEX KEY:			0000749660
		STANDARD INDUSTRIAL CLASSIFICATION:	SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
		IRS NUMBER:				020377419
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-09341
		FILM NUMBER:		23823625

	BUSINESS ADDRESS:	
		STREET 1:		98 SPIT BROOK ROAD, SUITE 100
		CITY:			NASHUA
		STATE:			NH
		ZIP:			03062
		BUSINESS PHONE:		603-882-5200

	MAIL ADDRESS:	
		STREET 1:		98 SPIT BROOK ROAD, SUITE 100
		CITY:			NASHUA
		STATE:			NH
		ZIP:			03062

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	HOWTEK INC
		DATE OF NAME CHANGE:	19920703
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>icad20230412_8k.htm
<DESCRIPTION>FORM 8-K
<TEXT>
<XBRL>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:naics="http://xbrl.sec.gov/naics/2021" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xsd="http://www.w3.org/2001/XMLSchema" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:us-types="http://fasb.org/us-types/2021-01-31" xmlns:utreg="http://www.xbrl.org/2009/utr" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:us-roles="http://fasb.org/us-roles/2020-01-31" xmlns:stpr="http://xbrl.sec.gov/stpr/2021" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:num="http://www.xbrl.org/dtr/type/numeric" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:thunderdome="http://www.RDGFilings.com" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:dei="http://xbrl.sec.gov/dei/2021q4" xmlns:us-gaap="http://fasb.org/us-gaap/2021-01-31" xmlns:country="http://xbrl.sec.gov/country/2021" xmlns:rr="http://xbrl.sec.gov/rr/2018-01-31" xmlns:sic="http://xbrl.sec.gov/sic/2021" xmlns:currency="http://xbrl.sec.gov/currency/2021" xmlns:exch="http://xbrl.sec.gov/exch/2021" xmlns:srt="http://fasb.org/srt/2021-01-31" xmlns:icad="http://www.icad.com/20230413"><head>
	<title>icad20230412_8k.htm</title>

	<!-- Created by RDG Portal -->
<meta http-equiv="Content-Type" content="text/html" /></head>
<body style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-right: 10px; margin-left: 10px; cursor: auto;"><div style="display: none">
<ix:header>
<ix:hidden>
<ix:nonNumeric contextRef="d20238K" name="dei:AmendmentFlag">false</ix:nonNumeric>
<ix:nonNumeric contextRef="d20238K" name="dei:EntityCentralIndexKey">0000749660</ix:nonNumeric>

</ix:hidden>
<ix:references>
<link:schemaRef xlink:href="icad-20230413.xsd" xlink:type="simple" />
</ix:references>
<ix:resources>
<xbrli:context id="d20238K">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0000749660</xbrli:identifier>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2023-04-13</xbrli:startDate>
<xbrli:endDate>2023-04-13</xbrli:endDate>
</xbrli:period>
</xbrli:context>


</ix:resources>
</ix:header>
</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<hr style="height: 1px; color: #000000; background-color: #000000; width: 100%; border: none; margin: 3pt 0" />
<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<hr style="height: 1px; color: #000000; background-color: #000000; width: 100%; border: none; margin: 3pt 0" />
<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family: &quot;Times New Roman&quot;; font-size: 16pt; font-variant: normal; margin: 0pt; text-align: center;"><b>UNITED STATES</b></div>

<div style="font-family: &quot;Times New Roman&quot;; font-size: 16pt; font-variant: normal; margin: 0pt; text-align: center;"><b>SECURITIES AND EXCHANGE COMMISSION</b></div>

<div style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt; text-align: center;"><b>WASHINGTON, DC 20549</b></div>

<div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;">&#xa0;</div>

<hr style="height: 1px; color: #000000; background-color: #000000; width: 100%; border: none; margin: 3pt 0" />
<div style="font-family: &quot;Times New Roman&quot;; font-size: 16pt; font-variant: normal; margin: 0pt; text-align: center;"><b>FORM <ix:nonNumeric contextRef="d20238K" name="dei:DocumentType"><b>8-K</b></ix:nonNumeric></b></div>

<hr style="height: 1px; color: #000000; background-color: #000000; width: 100%; border: none; margin: 3pt 0" />
<div style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt; text-align: center;"><b>CURRENT REPORT</b></div>

<div style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt; text-align: center;"><b>PURSUANT TO SECTION 13 OR 15(d)</b></div>

<div style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt; text-align: center;"><b>OF THE SECURITIES EXCHANGE ACT OF 1934</b></div>

<div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;">&#xa0;</div>

<div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;">&#xa0;</div>

<div style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; font-variant: normal; margin: 0pt; text-align: center;"><b>Date of report (Date of earliest event reported):</b>&#xa0;<ix:nonNumeric contextRef="d20238K" format="ixt:datemonthdayyearen" name="dei:DocumentPeriodEndDate"><b>April&#xa0;13</b><b>, 2023</b></ix:nonNumeric></div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<hr style="height: 1px; color: #000000; background-color: #000000; width: 100%; border: none; margin: 3pt 0" />
<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family: &quot;Times New Roman&quot;; font-size: 22pt; font-variant: normal; margin: 0pt; text-align: center;"><ix:nonNumeric contextRef="d20238K" name="dei:EntityRegistrantName"><b>iCAD, INC.</b></ix:nonNumeric></div>

<div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;"><b>(Exact Name of Registrant as Specified in Its Charter)</b></div>

<div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;">&#xa0;</div>

<hr style="height: 1px; color: #000000; background-color: #000000; width: 100%; border: none; margin: 3pt 0" />
<div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;">&#xa0;</div>

<div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;"><ix:nonNumeric contextRef="d20238K" format="ixt-sec:stateprovnameen" name="dei:EntityIncorporationStateCountryCode"><b>Delaware</b></ix:nonNumeric></div>

<div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;"><b>(State or Other Jurisdiction of Incorporation)</b></div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tbody><tr>
			<td style="vertical-align: middle; width: 49%;">
			<div style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;"><ix:nonNumeric contextRef="d20238K" name="dei:EntityFileNumber"><b>001-09341</b></ix:nonNumeric></div>
			</td>
			<td style="vertical-align: middle; width: 2%; text-align: center;">&#xa0;</td>
			<td style="vertical-align: middle; width: 49%;">
			<div style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;"><ix:nonNumeric contextRef="d20238K" name="dei:EntityTaxIdentificationNumber"><b>02-0377419</b></ix:nonNumeric></div>
			</td>
		</tr>
		<tr>
			<td style="vertical-align: middle; width: 49%;">
			<div style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;"><b>(Commission</b></div>

			<div style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;"><b>File Number)</b></div>
			</td>
			<td style="vertical-align: middle; width: 2%; text-align: center;">&#xa0;</td>
			<td style="vertical-align: middle; width: 49%;">
			<div style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;"><b>(IRS Employer</b></div>

			<div style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;"><b>Identification No.)</b></div>
			</td>
		</tr>
		<tr>
			<td style="vertical-align: middle; width: 49%; text-align: center;">&#xa0;</td>
			<td colspan="2" style="vertical-align: middle; width: 2%; text-align: center;">&#xa0;</td>
		</tr>
		<tr>
			<td style="vertical-align: middle; width: 49%;">
			<div style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;"><b><ix:nonNumeric contextRef="d20238K" name="dei:EntityAddressAddressLine1"><b>98 Spit Brook Road, Suite 100</b></ix:nonNumeric>, <ix:nonNumeric contextRef="d20238K" name="dei:EntityAddressCityOrTown"><b>Nashua</b></ix:nonNumeric>, <ix:nonNumeric contextRef="d20238K" format="ixt-sec:stateprovnameen" name="dei:EntityAddressStateOrProvince"><b>New Hampshire</b></ix:nonNumeric></b></div>
			</td>
			<td style="vertical-align: middle; width: 2%; text-align: center;">&#xa0;</td>
			<td style="vertical-align: middle; width: 49%;">
			<div style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;"><ix:nonNumeric contextRef="d20238K" name="dei:EntityAddressPostalZipCode"><b>03062</b></ix:nonNumeric></div>
			</td>
		</tr>
		<tr>
			<td style="vertical-align: middle; width: 49%;">
			<div style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;"><b>(Address of Principal Executive Offices)</b></div>
			</td>
			<td style="vertical-align: middle; width: 2%; text-align: center;">&#xa0;</td>
			<td style="vertical-align: middle; width: 49%;">
			<div style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;"><b>(Zip Code)</b></div>
			</td>
		</tr>

</tbody></table>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;"><b>(<ix:nonNumeric contextRef="d20238K" name="dei:CityAreaCode"><b>603</b></ix:nonNumeric>) <ix:nonNumeric contextRef="d20238K" name="dei:LocalPhoneNumber"><b>882-5200</b></ix:nonNumeric></b></div>

<div style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;"><b>(Registrant</b>&#8217;<b>s Telephone Number, Including Area Code)</b></div>

<div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;">&#xa0;</div>

<div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;">&#xa0;</div>

<div style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;"><b>Not Applicable</b></div>

<div style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;"><b>(Former Name or Former Address, if Changed Since Last Report)</b></div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<hr style="height: 1px; color: #000000; background-color: #000000; width: 100%; border: none; margin: 3pt 0" />
<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (<i>see </i>General Instruction A.2. below):</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tbody><tr>
			<td style="vertical-align:middle;width:auto;">&#xa0;</td>
			<td style="vertical-align:middle;width:auto;">
			<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"><ix:nonNumeric contextRef="d20238K" format="ixt-sec:boolballotbox" name="dei:WrittenCommunications">&#9744;</ix:nonNumeric></div>
			</td>
			<td style="vertical-align:middle;width:auto;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</div>
			</td>
		</tr>

</tbody></table>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tbody><tr>
			<td style="vertical-align:middle;width:auto;">&#xa0;</td>
			<td style="vertical-align:middle;width:auto;">
			<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"><ix:nonNumeric contextRef="d20238K" format="ixt-sec:boolballotbox" name="dei:SolicitingMaterial">&#9744;</ix:nonNumeric></div>
			</td>
			<td style="vertical-align:middle;width:auto;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</div>
			</td>
		</tr>

</tbody></table>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tbody><tr>
			<td style="vertical-align:middle;width:auto;">&#xa0;</td>
			<td style="vertical-align:middle;width:auto;">
			<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"><ix:nonNumeric contextRef="d20238K" format="ixt-sec:boolballotbox" name="dei:PreCommencementTenderOffer">&#9744;</ix:nonNumeric></div>
			</td>
			<td style="vertical-align:middle;width:auto;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</div>
			</td>
		</tr>

</tbody></table>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tbody><tr>
			<td style="vertical-align:middle;width:auto;">&#xa0;</td>
			<td style="vertical-align:middle;width:auto;">
			<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"><ix:nonNumeric contextRef="d20238K" format="ixt-sec:boolballotbox" name="dei:PreCommencementIssuerTenderOffer">&#9744;</ix:nonNumeric></div>
			</td>
			<td style="vertical-align:middle;width:auto;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</div>
			</td>
		</tr>

</tbody></table>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;">Securities registered pursuant to Section&#xa0;12(b) of the Act:</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tbody><tr>
			<td style="vertical-align: bottom; width: 32%;">
			<div style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;"><b>Title of each class</b></div>
			</td>
			<td style="vertical-align: middle; width: 2%; text-align: center;">&#xa0;</td>
			<td style="vertical-align: middle; width: 32%;">
			<div style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;"><b>Trading</b></div>

			<div style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;"><b>symbol(s)</b></div>
			</td>
			<td style="vertical-align: middle; width: 2%; text-align: center;">&#xa0;</td>
			<td style="vertical-align: middle; width: 32%;">
			<div style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;"><b>Name of each exchange</b></div>

			<div style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;"><b>on which registered</b></div>
			</td>
		</tr>
		<tr>
			<td style="vertical-align: middle; width: 32%;">
			<div style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;"><b><ix:nonNumeric contextRef="d20238K" name="dei:Security12bTitle"><b>Common Stock</b></ix:nonNumeric>, $0.01 par value</b></div>
			</td>
			<td style="vertical-align: middle; width: 2%; text-align: center;">&#xa0;</td>
			<td style="vertical-align: middle; width: 32%;">
			<div style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;"><ix:nonNumeric contextRef="d20238K" name="dei:TradingSymbol"><b>ICAD</b></ix:nonNumeric></div>
			</td>
			<td style="vertical-align: middle; width: 2%; text-align: center;">&#xa0;</td>
			<td style="vertical-align: middle; width: 32%;">
			<div style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;"><b>The <ix:nonNumeric contextRef="d20238K" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName"><b>Nasdaq</b></ix:nonNumeric> Stock Market LLC</b></div>
			</td>
		</tr>

</tbody></table>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167;240.12b-2 of this chapter). Emerging growth company&#xa0;&#xa0;<ix:nonNumeric contextRef="d20238K" format="ixt-sec:boolballotbox" name="dei:EntityEmergingGrowthCompany">&#9744;</ix:nonNumeric></div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section&#xa0;13(a) of the Exchange Act.&#xa0;&#xa0;&#9744;</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<hr style="height: 1px; color: #000000; background-color: #000000; width: 100%; border: none; margin: 3pt 0" />
<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<hr style="height: 1px; color: #000000; background-color: #000000; width: 100%; border: none; margin: 3pt 0" />
<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">&#xa0;</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000" />
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&#xa0;</div>
</div>
</div>
</div>

<div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&#xa0;</div>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tbody><tr>
			<td style="vertical-align: middle; width: 78px;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Item</b>&#xa0;<b>1.01.</b></div>
			</td>
			<td style="vertical-align: middle; width: 1666px;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Entry Into a Material Definitive Agreement</b></div>
			</td>
		</tr>

</tbody></table>

<div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&#xa0;</div>

<div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">The disclosure set forth under Item 5.02 of this Current Report on Form 8-K is incorporated by reference into this Item 1.01.</div>

<div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&#xa0;</div>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tbody><tr>
			<td style="vertical-align: middle; width: 78px;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Item</b>&#xa0;<b>5.02.</b></div>
			</td>
			<td style="vertical-align: middle; width: 1666px;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.</b></div>
			</td>
		</tr>

</tbody></table>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt -1pt;">On April 17, 2023, Eric&#xa0;Lonnqvist, age 48, was appointed&#xa0;Chief Financial Officer of iCAD, Inc. (the "Company"), effective immediately.</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt -1pt;">In connection with this&#xa0;appointment, Mr. Lonnqvist and the Company entered into an Employment Agreement providing for (i) an annual base salary of $250,000; (ii) eligibility to participate in the Company's annual discretionary bonus plan for executives, with the potential to earn a cash and/or equity-based bonus equal to up to twenty five&#xa0;(25%) percent of Mr. Lonnqvist's&#xa0;base salary; (iii)&#xa0;eligibility to participate in the Company&#8217;s benefit plans; (iv)&#xa0;reimbursement for reasonable out-of-pocket expenses; and (v)&#xa0;options to acquire 100,000&#xa0;shares of common stock, subject to a 3-year vesting schedule and a 10-year expiration period. The Employment Agreement subjects Mr. Lonnqvist&#xa0;to standard restrictive covenants for agreements of its type, including non-competition and non-solicitation.</div>

<div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt -9pt;">&#xa0;</div>

<div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt -1pt;">Mr. Lonnqvist has served as Vice President, Financial Planning and Analysis since February 2021. Mr. Lonnqvist served from July 2017 to January 2021 as Director of Financial Planning and Analysis at NetBrain Technologies. Prior to that role, he served as Director of Revenue Analytics at TripAdvisor and had varying roles of increasing responsibility at software companies including Interactive Data Corporation, Art Technology Group(acquired by Oracle), and Workscape (acquired by ADP).&#xa0;</div>

<div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt -9pt;">&#xa0;</div>

<div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt -1pt;">There are no arrangements or understandings between Mr. Lonnqvist and any other persons pursuant to which he was selected as Chief Financial Officer. There are no family relationships between Mr.&#xa0;Lonnqvist and the directors, nor between Mr. Lonnqvist and any executive officer, of the Company.</div>

<div style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;">&#xa0;</div>

<div style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;">&#xa0;</div>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tbody><tr>
			<td style="vertical-align: middle; width: 62px;"><b>Item&#xa0;7.01.</b></td>
			<td style="vertical-align: middle; width: 1682px;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>&#xa0;Regulation FD Disclosure.</b></div>
			</td>
		</tr>

</tbody></table>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt -1pt;">On April 17,&#xa0;2023, the Company issued a press release, a copy of which is filed herewith as Exhibit 99.1, announcing the CFO appointment. The information set forth in this Item 7.01&#xa0;and in Exhibit 99.1 is furnished and shall not be deemed &#8220;filed&#8221; for purposes of Section&#xa0;18 of the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;), or otherwise subject to the liabilities of that section. The information in this Item 7.01&#xa0;and in Exhibit 99.1 shall not be deemed to be incorporated by reference into any filing of the Company under the&#xa0;Securities Act, or the&#xa0;Exchange Act, whether made before or after the date hereof, except as shall be expressly set forth by specific reference in such a filing.</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tbody><tr>
			<td style="vertical-align: middle; width: 67px;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Item</b>&#xa0;<b>9.01.</b></div>
			</td>
			<td style="vertical-align: middle; width: 1677px;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Financial Statements and Exhibits</b></div>
			</td>
		</tr>

</tbody></table>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 8pt;">Exhibit 99.1 is being furnished pursuant to Item 9.01, is not to be considered filed under the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;), and shall not be incorporated by reference into any of the Company&#8217;s previous or future filings under the Securities Act of 1933, as amended, or the Exchange Act.</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tbody><tr>
			<td style="vertical-align:middle;width:auto;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">10.1</div>
			</td>
			<td style="vertical-align:middle;width:auto;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><a href="ex_501441.htm" style="-sec-extract:exhibit;">Employment Agreement between iCAD, Inc. and Eric Lonnqvist, dated April 13, 2023</a></div>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:middle;width:auto;">&#xa0;</td>
			<td style="vertical-align:middle;width:auto;">&#xa0;</td>
		</tr>
		<tr>
			<td style="vertical-align:middle;width:auto;">99.1</td>
			<td style="vertical-align:middle;width:auto;"><a href="ex_501442.htm" style="-sec-extract:exhibit;">Press release dated April 17, 2023</a></td>
		</tr>
		<tr>
			<td style="vertical-align:middle;width:auto;">&#xa0;</td>
			<td style="vertical-align:middle;width:auto;">&#xa0;</td>
		</tr>
		<tr>
			<td style="vertical-align:middle;width:auto;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">104</div>
			</td>
			<td style="vertical-align:middle;width:auto;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Cover Page Interactive Data File (embedded within the Inline XBRL document)</div>
			</td>
		</tr>

</tbody></table>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<hr style="height: 1px; color: #000000; background-color: #000000; width: 100%; border: none; margin: 3pt 0" />
<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">&#xa0;</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000" />
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&#xa0;</div>
</div>
</div>
</div>

<div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&#xa0;</div>

<div style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;"><b>SIGNATURES </b></div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;">Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tbody><tr>
			<td style="vertical-align: middle; width: 65%;">&#xa0;</td>
			<td colspan="2" style="vertical-align: middle; width: 5%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">iCAD, INC.</div>

			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">(Registrant)</div>
			</td>
		</tr>
		<tr>
			<td style="vertical-align: middle; width: 65%;">&#xa0;</td>
			<td style="vertical-align: middle; width: 5%;">&#xa0;</td>
			<td style="vertical-align: middle; width: 30%;">&#xa0;</td>
		</tr>
		<tr>
			<td style="vertical-align: middle; width: 65%;">&#xa0;</td>
			<td style="vertical-align: middle; width: 5%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">By:</div>
			</td>
			<td style="vertical-align: middle; width: 30%; border-bottom: 1px solid rgb(0, 0, 0);">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">/s/ Dana Brown</div>
			</td>
		</tr>
		<tr>
			<td style="vertical-align: middle; width: 65%;">&#xa0;</td>
			<td style="vertical-align: middle; width: 5%;">&#xa0;</td>
			<td style="vertical-align: middle; width: 30%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Dana Brown</div>

			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">President and Chief Executive Officer</div>
			</td>
		</tr>

</tbody></table>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;">Date: April 17, 2023</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div class="LAST-PAGE-BREAK">
<div class="PGFTR">
<div class="hf-row">
<div class="hf-cell PGNUM">&#xa0;</div>
</div>
</div>
</div>


</body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>2
<FILENAME>ex_501441.htm
<DESCRIPTION>EXHIBIT 10.1
<TEXT>
<html><head>
	<title>ex_501441.htm</title>

	<!-- Generated by ThunderDome Portal - 4/17/2023 5:41:38 PM --><meta charset="utf-8"><meta name="format-detection" content="telephone=no">
</head>
<body style="font-size: 10pt; font-family: &quot;Times New Roman&quot;; padding: 0in 0.1in; cursor: auto;">
<div>&nbsp;</div>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt 0pt 0pt 11pt;"><b>Exhibit 10.1</b></p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt 0pt 0pt 11pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; width: 100%;">

		<tr>
			<td style="width: 50%;">
			<div><img alt="b01.jpg" src="b01.jpg"></div>
			</td>
			<td style="width: 50%;">
			<div style="text-align: right;"><img alt="b02.jpg" src="b02.jpg"></div>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">April 11, 2023</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Eric Lonnqvist</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Dear Eric -</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">We are pleased and excited to offer you employment with iCAD as Chief Financial Officer, reporting to Dana Brown, President &amp; CEO with a start date of April 17, 2023, under the following terms. We look forward to your contribution and hope that together we can turn our new and growing company into a world-class supplier of innovative and clinically relevant applications.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Your base salary will be equivalent to $250,000 annually, which will be paid in bi-weekly installments, subject to deductions for taxes and other withholdings as required by law or the policies of the company.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">You may be eligible for a 2023 prorated discretionary bonus up to 25% of your base salary, based on individual performance and company financials. Your annualized On-Target earnings will be $312,5000.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">You will be offered iCAD incentive stock options, subject to a 3-year vesting schedule of 1/3 per year and a 10-year expiration period. The incentive stock options will be issued to you upon your hire date at the amount of 100,000. You will be given written documentation explaining the incentive stock option plan in detail, upon approval.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">iCAD&#8217;s proprietary rights and confidential information are among the company&#8217;s most important assets. We must therefore ask that you sign, if you have not previously, the enclosed policies.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">As is true for all iCAD employees, your employment with iCAD will be &#8220;at will&#8221;, meaning that either you or iCAD may terminate your employment at any time for any reason. Also, your employment is conditioned on you successfully completing and satisfactorily passing a pre-employment background check and possessing proper work authorization in the United States.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">To accept this offer, please sign this letter confirming your intended start date your new role in the line below. Please return the full and completed signed offer letter within 7 business days from the date of this offer. iCAD has the right to refuse any offer that is not returned in this outlined time period.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">If you have any questions, please feel free to me at 617.359.1600 or email me at <u>btesta@icadmed.com</u>. We look forward to having you begin work with us.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Sincerely,</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div><img alt="b03.jpg" src="b03.jpg"></div>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Brian Testa</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">People &amp; Culture</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">I hereby accept this offer of employment: Eric Lonnqvist</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; width: 100%;">

		<tr>
			<td style="width: 12%; border-bottom: 1px solid rgb(0, 0, 0);"><i><sup style="vertical-align:top;line-height:120%;font-size:pt">Eric Lonnqvist</sup></i>&nbsp;</td>
			<td style="width: 1%;">&nbsp;</td>
			<td style="width: 12%; border-bottom: 1px solid rgb(0, 0, 0);">Apr 13, 2023</td>
			<td style="width: 1%;">&nbsp;</td>
			<td style="width: 12%; border-bottom: 1px solid rgb(0, 0, 0);">Apr 17, 2023</td>
			<td style="width: 2%;">&nbsp;</td>
			<td style="width: 60%;">&nbsp;</td>
		</tr>
		<tr>
			<td style="text-align: center; width: 12%;">Signature&nbsp;</td>
			<td style="text-align: center; width: 1%;">&nbsp;</td>
			<td style="text-align: center; width: 12%;">Date&nbsp;</td>
			<td style="text-align: center; width: 1%;">&nbsp;</td>
			<td style="text-align: center; width: 12%;">Start Date:</td>
			<td style="width: 2%;">&nbsp;</td>
			<td style="width: 60%;">&nbsp;</td>
		</tr>

</table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">&nbsp; &nbsp; &nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 46pt;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<hr style="height: 1px; color: #000000; background-color: #000000; width: 100%; border: none; margin: 3pt 0">
<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">98 Spit Brook Road, Suite 100 Nashua, NH 03062</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">phone: 603.882.5200&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;toll free: 866.280.2239&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;fax: 603.218.6658</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">www.icadmed.com</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">&nbsp;</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt 0pt 0pt 24pt;"><b><u>SEVERANCE AND CHANGE IN CONTROL AGREEMENT</u></b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 36pt;">This Agreement (the &#8220;Agreement&#8221;) is entered into as of the <u><sup style="vertical-align:top;line-height:120%;font-size:pt"> 17 </sup></u>th day of April 2023 by and between iCAD, Inc., a Delaware corporation (the &#8220;Company&#8221;), and Eric Lonnqvist (the &#8220;Executive&#8221;).</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 36pt;"><b>WHEREAS </b>Executive is employed by the Company, and because of such employment, possesses detailed knowledge of the Company and its business and operations.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 36pt;"><b>WHEREAS </b>Executive&#8217;s continued service to the Company is very important to the future success of the Company;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 36pt;"><b>WHEREAS </b>the Company desires to enter into this Agreement to provide Executive with certain financial protection in the event that Executive&#8217;s employment terminates under certain circumstances, and thereby to provide Executive with incentives to remain with the Company</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 36pt;"><b>WHEREAS </b>the President and the Senior Executive Management team have determined that it is in the best interests of the Company to enter into this Agreement.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 36pt;"><b>NOW THEREFORE </b>for good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the Company and Executive agree as follows:</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"><b>1.&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;<u>Definitions</u></b><b>.</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">(a)&nbsp;&nbsp;&nbsp;&nbsp;<u>Cause</u>. As used herein, &#8220;Cause&#8221; shall mean the occurrence of any of the following events: (i) Executive&#8217;s dishonesty with respect to the Company or any affiliate, parent or subsidiary of the Company; (ii) Executive&#8217;s insubordination; (iii) the Executive having committed acts or omissions constituting gross negligence or willful misconduct (including theft, fraud, embezzlement, and securities law violations) which is injurious to the Company, monetarily, or otherwise; (iv) the willful failure by the Executive to substantially perform his employment-related duties and/or responsibilities to the Company; (v) Executive&#8217;s unauthorized use or disclosure of the Company&#8217;s confidential information; (vi) the indictment of the Executive for a felony or other crime involving moral turpitude or dishonesty; (vii) Executive&#8217;s breach of any material provision of any employment, consulting, advisory, non-disclosure, non-competition, or similar material agreement between Executive and the Company, which breach, where reasonably subject to cure, is not cured to the satisfaction of the CEO within ten (10) days after written notice to Executive by the Company reasonably describing such breach; or (viii) conduct substantially prejudicial to the business of the Company or any affiliate, parent or subsidiary of the Company. The CEO shall have sole discretion to determine the existence of &#8220;Cause,&#8221; provided that the CEO may delegate its power to determine the existence of &#8220;Cause,&#8221; under this paragraph to an Executive Officer of the Company. In the event that the conduct or breach under (vii) above is not, in the sole opinion of the CEO, capable of cure, or if, in the sole opinion of the CEO, Executive has failed to adequately cure the reasons giving rise to a termination for &#8220;Cause&#8221; under (vii) above, then Executive&#8217;s employment may be terminated immediately provided Company pays Executive his base salary for fourteen (14) days. In no event, however, will Executive be provided with an opportunity to &#8220;cure&#8221; any conduct, actions, failures to act, events, or breaches giving rise to a termination for &#8220;Cause&#8221; under (i), (ii), (iii), (iv), (v), (vi) or (viii) above, and any such termination pursuant to (i), (ii), (iii), (iv), (v), (vi) or (viii) above are and will be considered incapable of being &#8220;cured.&#8221;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">&nbsp;</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<div contenteditable="false" data-applyto="t" data-auto-pgnum="start" data-displaynum="2" data-fontname="Times New Roman" data-fontsize="10pt" data-numstyle="a" data-prefix="" data-startnum="2" data-suffix="" data-textalign="center">&nbsp;</div>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt; text-align: justify;">(b)&nbsp;&nbsp; &nbsp;&nbsp;<u>Change In Control</u>. As used herein, a &#8220;Change in Control&#8221;&nbsp;shall mean:&nbsp;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 63pt; text-align: justify;">(i)&nbsp;&nbsp;&nbsp;&nbsp;the shareholders of the Company approve: (a) any consolidation or merger of the Company where the shareholders of the Company, immediately prior to the consolidation or merger, would not, immediately after the consolidation or merger, beneficially own, directly or indirectly, shares representing in the aggregate more than 50% of the combined voting power of all the outstanding securities of the corporation issuing cash or securities in the consolidation or merger (or of its ultimate parent corporation, if any); (b) any sale, lease, exchange or other transfer (in one transaction or a series of transactions contemplated or arranged by any party as a single plan) of all or substantially all of the assets of the Company; or (c) any plan or proposal for the liquidation or dissolution of the Company; or</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 63pt; text-align: justify;">(ii)&nbsp;&nbsp;&nbsp;&nbsp;any &#8220;person,&#8221; as such term is used in Section 13(d) of the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;) (other than the Company, any employee benefit plan of the Company or any entity organized, appointed or established by the Company for or pursuant to the terms of such plan), together with all &#8220;affiliates&#8221; and &#8220;associates&#8221; (as such terms are defined in Rule 12b-2 under the Exchange Act) of such person, shall become the &#8220;beneficial owner&#8221; or &#8220;beneficial owners&#8221; (as defined in Rules 13d-3 and 13d-5 under the Exchange Act), directly or indirectly, of securities of the Company representing in the aggregate 25% or more of either: (a) the then outstanding shares of the Common Stock of the Company or (b) the combined voting power of all then outstanding securities of the Company having the right under ordinary circumstances to vote in an election of the Board (&#8220;Voting Securities&#8221;) (in either such case, other than as a result of acquisitions of such securities directly from the Company).</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 36pt;">Notwithstanding the foregoing, a &#8220;Change in Control&#8221; of the Company shall not be deemed to have occurred for purposes of the foregoing clause (ii) solely as the result of an acquisition of securities by the Company which, by reducing the number of shares of Common Stock or other Voting Securities outstanding, increases: (a) the proportionate number of shares of Common Stock beneficially owned by any person to 25% or more of the Common Stock then outstanding, or (b) the proportionate voting power represented by the Voting Securities beneficially owned by any person to 25% or more of the combined voting power of all then outstanding Voting Securities; provided, however, that if any person referred to in clause (a) or (b) of this sentence shall thereafter become the beneficial owner of any additional shares of Common Stock or other Voting Securities (other than pursuant to a stock split, stock dividend or similar transaction), then a &#8220;Change in Control&#8221; shall be deemed to have occurred for purposes of the foregoing clause (ii).</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="2" data-prefix="" data-suffix="" style="text-align: center; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">2</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">(c)&nbsp;&nbsp;&nbsp;&nbsp;<u>Disability</u>. As used herein, &#8220;Disability&#8221; means Executive&#8217;s incapacity or inability to perform their duties and responsibilities to the Company, with or without reasonable accommodation, for ninety (90) days or more within any one (1) year period (cumulative or consecutive), because Executive&#8217;s physical or mental health has become so impaired as to make it impossible or impractical for Executive to perform the duties and responsibilities contemplated hereunder, with or without reasonable accommodation. Determination of Executive&#8217;s physical or mental health will be determined by the Board after consultation with a medical expert (who has examined Executive), and such medical expert shall be appointed by the Board using its reasonable judgment. Executive hereby consents to such examination and consultation regarding his health and ability to perform as aforesaid. If Executive is determined to have a Disability as provided herein, then the date of such Disability shall be considered to have occurred as of the end of the ninety (90) day time period referenced herein.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">(d)&nbsp;&nbsp;&nbsp;&nbsp;<u>Good Reason</u>. As used herein, a &#8220;Good Reason&#8221; shall mean any action by the Company without Executive&#8217;s prior written consent which results in (i) any requirement by the Company that Executive perform Executive&#8217;s principal duties outside a radius of <b>25 </b>miles from the Company's Nashua location; (ii) any material diminution in Executive&#8217;s title, position, duties, responsibilities or authority; (iii) any breach by the Company of any material provision contained herein; or (iv) a material reduction in Executive&#8217;s base salary (unless such reduction is effected in connection with a general and proportionate reduction of salaries for all similarly situated Company employees). Notwithstanding the foregoing, &#8220;Good Reason&#8221; shall not be deemed to have occurred unless: (a) Executive provides the Company with written notice that he intends to terminate his employment hereunder for the grounds set forth above within thirty (30) days of such reason(s) occurring; (b) if such ground is capable of being cured, the Company has failed to cure such ground within a period of thirty (30) days from the date of such written notice; and (c) Executive terminates his employment within six (6) months from the date that Good Reason first occurs. For purposes of clarification, the above-listed conditions shall apply separately to each occurrence of Good Reason and failure to adhere to such conditions in the event of Good Reason shall not disqualify Executive from asserting Good Reason for any subsequent occurrence of Good Reason.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">(e)&nbsp;&nbsp;&nbsp;&nbsp;<u>Base Salary</u>. As used herein, &#8220;Base Salary&#8221; shall mean Executive&#8217;s annual base salary at the time of termination, excluding reimbursements, bonuses, benefits, and amounts attributable to stock options and other non-cash compensation.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b>2.&nbsp; &nbsp;&nbsp; &nbsp; &nbsp;&nbsp;<u>Standard Severance</u></b><b>. </b>In the event that Executive&#8217;s employment is either (i) involuntarily terminated by action of the Company other than for Cause or (ii) Executive terminates Executive&#8217;s employment voluntarily for Good Reason, Executive shall receive the following (subject to Executive&#8217;s execution of a release of claims as described in <u>Section 7</u>):</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">(a)&nbsp;&nbsp;&nbsp;&nbsp;<u>Severance Payments</u>. Continuation of payments in an amount equal to Executive&#8217;s then-current Base Salary for the <b>six (6) </b>month period immediately following the termination of Executive&#8217;s employment (the &#8220;Severance Period,&#8221; if <u>Section</u> <u>2</u> applies) less all customary and required taxes and employment-related deductions, in substantially equal installments in accordance with the Company&#8217;s normal payroll practices. The payments will commence within ninety (90) days following both the date of the termination of the Executive&#8217;s employment and the date that the release of claims described in <u>Section</u> <u>7</u> is effective and irrevocable. The first payment shall include those installments that would have been paid as of the payment commencement date had the payments commenced in the first payroll period following the termination date.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="3" data-prefix="" data-suffix="" style="text-align: center; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">3</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">(b)&nbsp;&nbsp;&nbsp;&nbsp;<u>COBRA Payments</u>. Upon completion of the appropriate COBRA<sup style="vertical-align:top;line-height:120%;font-size:pt">1/</sup> forms, and subject to all the requirements of COBRA, the Company shall continue Executive&#8217;s participation in the Company&#8217;s health and dental insurance plans at the Company&#8217;s cost (except for Executive&#8217;s co- pay, if any, which shall be deducted from Executive&#8217;s severance compensation) for the <b>six (6) </b>month COBRA eligibility period following termination, to the same extent that such insurance is provided to similarly situated Company executives, <i>provided that </i>this benefit will cease and the Company will be under no obligation to provide it if Executive has become eligible for coverage under another employer&#8217;s group coverage, and Executive hereby agrees to notify the Company promptly and in writing should that occur. If the payment of any COBRA or health insurance premiums on Executive&#8217;s behalf would otherwise violate the nondiscrimination rules or cause the reimbursement of claims to be taxable under the Patient Protection and Affordable Care Act of 2010, together with the Health Care and Education Reconciliation Act of 2010 (collectively, the &#8220;Healthcare Reform Act&#8221;) or Section 105(h) of the Internal Revenue Code of 1986, as amended (the &#8220;Code&#8221;), the Company paid premiums shall be treated as taxable payments and be subject to imputed income tax treatment to the extent necessary to eliminate any discriminatory treatment or taxation under the Act or Section 105(h) of the Code.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">(c)&nbsp;&nbsp;&nbsp;&nbsp;<u>No Duplication</u>. In the event that Executive is eligible for Change in Control Severance under <u>Section 3</u> below, Executive shall not be eligible for and shall not receive the Standard Severance as provided in this <u>Section 2</u>.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b>3.&nbsp; &nbsp; &nbsp; &nbsp; <u>Change In Control Severance</u></b><b>. </b>In the event that a Change in Control occurs and within a period of six (6) months following the Change in Control, either: (i) Executive&#8217;s employment is involuntarily terminated by action of the Company other than for Cause, or (ii) Executive terminates Executive&#8217;s employment voluntarily for Good Reason, then Executive shall receive the following (subject to Executive&#8217;s execution of a release of claims, as described in <u>Section 7</u>):</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 18pt;">&nbsp;</td>
			<td style="width: 18pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">(a)</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><u>Severance Payments</u>. Continuation of payments in an amount equal to Executive&#8217;s then current Base Salary for the <b>six (6) </b>month period immediately following the termination of Executive&#8217;s employment (the &#8220;CIC Severance Period,&#8221;&nbsp;if <u>Section</u>&nbsp;<u>3</u>&nbsp;applies) less all customary and required taxes and employment-related deductions, in substantially equal installments in accordance with the Company&#8217;s normal payroll practices. The payments will commence within ninety (90) days following both the date of the termination of the Executive&#8217;s employment and the date that the release of claims described in <u>Section</u>&nbsp;<u>7</u>&nbsp;is effective and irrevocable. The first payment shall include those installments that would have been paid as of the payment commencement date had the payments commenced in the first payroll period following the termination date.</p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">(b)&nbsp;&nbsp;&nbsp;&nbsp;If within six (6) months after the occurrence of a Change in Control, the Company shall terminate the Executive&#8217;s employment without Cause or Executive resigns for Good Reason, then notwithstanding the vesting and exercisability schedule in any stock option or other equity award agreement between the Company and the Executive, all unvested stock options and other equity&nbsp;awards granted by the Company to the Executive pursuant to such agreement shall immediately vest and become exercisable and shall remain exercisable for not less than one year thereafter.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 29pt;"><sup style="vertical-align:top;line-height:120%;font-size:pt">1/</sup>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#8220;COBRA&#8221; is the Consolidated Omnibus Budget Reconciliation Act of 1985, as amended.</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 29pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="4" data-prefix="" data-suffix="" style="text-align: center; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">4</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">(b)&nbsp;&nbsp;&nbsp;&nbsp;<u>COBRA Payments</u>. Upon completion of the appropriate COBRA forms, and subject to all the requirements of COBRA, continuation of Executive&#8217;s participation in the Company&#8217;s health and dental insurance plans at the Company&#8217;s cost (except for Executive&#8217;s co-pay, if any, which shall be deducted from Executive&#8217;s severance compensation) for the <b>six (6) </b>month COBRA eligibility period following such termination, to the same extent that such insurance is provided to similarly situated Company executives. If the payment of any COBRA or health insurance premiums on the Executive&#8217;s behalf would otherwise violate the nondiscrimination rules or cause the reimbursement of claims to be taxable under the Healthcare Reform Act or Section 105(h) of the Code, the Company paid premiums shall be treated as taxable payments and be subject to imputed income tax treatment to the extent necessary to eliminate any discriminatory treatment or taxation under the Act or Section 105(h) of the Code.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">(c)&nbsp;&nbsp;&nbsp;&nbsp;<u>No Duplication</u>. In the event that Executive is eligible for Standard Severance under <u>Section 2</u> above and the eligibility for Standard Severance has not occurred within a period of one (1) year following a Change in Control, Executive shall not be eligible for and shall not receive the Change in Control Severance as provided in this <u>Section 3</u>.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b>4.&nbsp; &nbsp; &nbsp; &nbsp; &nbsp;<u>No Severance</u></b><b>. </b>In the event that Executive&#8217;s employment is terminated for any reason other than those outlined in <u>Sections 2</u> or <u>3</u> (including a termination of Executive&#8217;s employment in the event of his death or Disability), then Executive shall have no right to the severance payments/benefits provided under this Agreement.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b>5.</b><b>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;<u>Distribution Limitation</u></b><b>. </b>If any payment or benefit Executive would receive under this Agreement, when combined with any other payment or benefit Executive receives pursuant to a Change in Control (for purposes of this section, a &#8220;Payment&#8221;) would: (i) constitute a &#8220;parachute payment&#8221; within the meaning of Section 280G of the Internal Revenue Code of 1986, as amended (the &#8220;Code&#8221;); and (ii) but for this sentence, be subject to the excise tax imposed by Section 4999 of the Code (the &#8220;Excise Tax&#8221;), then such Payment shall be either: (x) the full amount of such Payment; or (y) such lesser amount (with cash payments being reduced before stock option compensation) as would result in no portion of the Payment being subject to the Excise Tax, whichever of the foregoing amounts, taking into account the applicable federal, state and local employments taxes, income taxes, and the Excise Tax, results in Executive&#8217;s receipt, on an after- tax basis, of the greater amount of the Payment notwithstanding that all or some portion of the Payment may be subject to the Excise Tax.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="5" data-prefix="" data-suffix="" style="text-align: center; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">5</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b>6.</b><b>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; <u>Timing Of Payments</u></b><b>. </b>It is intended that each installment of the payments and benefits provided under <u>Sections</u> <u>2</u> and <u>3</u> of this Agreement shall be treated as a separate &#8220;payment&#8221; for purposes of Section 409A of the Code. If any of the payments set forth in <u>Sections</u> <u>2</u> or <u>3</u> of this Agreement payable in connection with the Executive&#8217;s termination of employment constitute &#8220;non-qualified deferred compensation&#8221; subject to Section 409A of the Code, then the following conditions apply to the payment of the benefits in <u>Sections</u> <u>2</u> and <u>3</u>: (i) any termination of the Executive&#8217;s employment triggering payment of benefits under <u>Sections</u> <u>2</u> or <u>3</u> must constitute a &#8220;separation from service&#8221; under Section 409A(a)(2)(A)(i) of the Code and Treas. Reg. &#167;1.409A- 1(h) before distribution of such benefits can commence. To the extent that the termination of the Executive&#8217;s employment does not constitute a separation of service under Section 409A(a)(2)(A)(i) of the Code and Treas. Reg. &#167;1.409A-1(h) (as the result of further services that are reasonably anticipated to be provided by the Executive to the Company at the time the Executive&#8217;s employment terminates), any benefits payable under <u>Sections</u> <u>2</u> or <u>3</u> that constitute non-qualified deferred compensation under Section 409A shall be delayed until after the date of a subsequent event constituting a separation of service under Section 409A(a)(2)(A)(i) of the Code and Treas. Reg. &#167;1.409A-1(h). For purposes of clarification, this <u>Section</u> <u>6</u> shall not cause any forfeiture of benefits on the Executive&#8217;s part, but shall only act as a delay until such time as a &#8220;separation from service&#8221; occurs; (ii) if the Executive is a &#8220;specified employee&#8221; (as that term is used in Section 409A and regulations and other guidance issued thereunder) on the date his separation from service becomes effective, any benefits payable under <u>Sections</u> <u>2</u> or <u>3</u> that constitute non-qualified deferred compensation subject to Section 409A shall be delayed until the earlier of (A) the business day following the six-month anniversary of the date his separation from service becomes effective, and (B) the date of the Executive&#8217;s death, but only to the extent necessary to avoid the adverse tax consequences and penalties under Section 409A. On the earlier of (A) the business day following the six-month anniversary of the date his separation from service becomes effective, and (B) the Executive&#8217;s death, the Company shall pay the Executive in a lump sum the aggregate value of the non-qualified deferred compensation that the Company otherwise would have paid the Executive prior to that date under <u>Sections</u> <u>2</u> or <u>3</u> of this Agreement; (iii) if the ninety (90) day period in which the payments will commence under <u>Sections</u> <u>2</u> or <u>3</u> begins in one taxable of the Executive and ends in the following taxable year, the payments will commence in the later taxable year; and (iv) neither the Company nor the Executive shall have the right to accelerate or defer the delivery of any such payments or benefits except to the extent specifically permitted or required by Section 409A.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b>7.&nbsp; &nbsp; &nbsp; &nbsp;&nbsp;</b><b><u>Release of Claims</u></b><b>. </b>The Company shall not be obligated to pay Executive and Executive shall not be eligible or otherwise entitled to receive any of the compensation set forth in <u>Sections</u> <u>2</u> and/or <u>3</u> of this Agreement unless and until Executive has executed and delivered to the Company a fully enforceable and non-revocable separation agreement, which shall contain, at a minimum, a full and general release of all claims against the Company (including its affiliates, parents and subsidiaries and its and their officers, directors, employees, and agents, in a form satisfactory to the Company) as well as non-disparagement and confidentiality obligations in favor of the Company.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b>8.&nbsp; &nbsp; &nbsp; &nbsp; &nbsp;</b><b><u>Restrictive Covenants</u></b><b>. </b>Executive acknowledges and agrees that this Agreement provides Executive with payments and benefits above and beyond those which the Company already is providing Executive. In exchange for the payments and benefits provided herein, as well as other good and valuable consideration, Executive agrees to the following restrictive covenants:</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="6" data-prefix="" data-suffix="" style="text-align: center; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">6</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">(a)&nbsp;&nbsp;&nbsp;&nbsp;While Executive is employed by the Company and for the twelve (12) month period immediately following the termination of the Executive&#8217;s employment with the Company (for any or no reason) (the &#8220;Non-Competition Period&#8221;), the Executive shall not, directly or indirectly, whether as owner, partner, investor, consultant, agent, employee, co-venturer or otherwise, compete with the Company or any affiliate, parent or subsidiary of the Company or undertake any planning for any business competitive with the Company or any affiliate, parent or subsidiary of the Company. For the purpose of this section, a business will be deemed to &#8220;compete&#8221; or be &#8220;competitive&#8221; if it performs any of the services or manufactures or sells any of the products provided or offered by the Company or if it performs any other services and/or engages in the marketing, production, manufacture, distribution or sale of any product or service similar to the services or products which were performed, produced, marketed, manufactured, distributed, sold, under development or planned by the Company during your affiliation with the Company, or which could substitute for such products or services.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">(b)&nbsp;&nbsp;&nbsp;&nbsp;During the Non-Competition Period, the Executive shall not recruit or otherwise solicit or induce any employees of the Company or any affiliate, parent or subsidiary of the Company to terminate their employment with, or otherwise cease their relationships with, the Company or any affiliate, parent or subsidiary of the Company.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">(c)&nbsp;&nbsp;&nbsp;&nbsp;The restrictions against competition set forth in paragraph 8(a) are considered by the parties to be reasonable for the purposes of protecting the business of the Company. However, if any such restriction is found by any court of competent jurisdiction to be unenforceable because it extends for too long a period of time or over too great a range of activities or in too broad a geographic area, it shall be interpreted to extend only over the maximum period of time, range of activities or geographic areas as to which it may be enforceable.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b>9.</b><b>&nbsp; &nbsp; &nbsp;&nbsp; &nbsp; &nbsp;<u>No Impact On Employment Status</u></b><b>. </b>This Agreement is not intended to confer, and shall not be interpreted as conferring, any additional employment rights on Executive, and has no impact on either party&#8217;s right to terminate Executive&#8217;s employment under contract or applicable law.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b>10.</b><b>&nbsp; &nbsp; &nbsp; &nbsp;<u>Enforceability; Reduction</u></b><b>. </b>If any provision of this Agreement shall be deemed invalid or unenforceable as written, this Agreement shall be construed, to the greatest extent possible, or modified, to the extent allowable by law, in a manner which shall render it valid and enforceable and any limitation on the scope or duration of any provision necessary to make it valid and enforceable shall be deemed to be a part thereof. No invalidity or unenforceability of any provision contained herein shall affect any other portion of this Agreement.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"><b>11.&nbsp; &nbsp; &nbsp; &nbsp; &nbsp;<u>Notices</u></b><b>.</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">(a)&nbsp;&nbsp;&nbsp;&nbsp;All notices, requests, consents and other communications hereunder shall be in writing, shall be addressed to the receiving party&#8217;s address set forth below or to such other address as a party may designate by notice hereunder, and shall be either (i) delivered by hand, (ii) made by telex, telecopy or facsimile transmission, (iii) sent by overnight courier, or (iv) sent by registered or certified mail, return receipt requested, postage prepaid.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify; text-indent: 36pt;"><i>If to the Company:</i></p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 63pt;">iCAD, Inc.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 63pt;">98 Split Brook Road, Suite 100</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 63pt;">Nashua, New Hampshire 03062</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 63pt;">Attn: CEO</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="7" data-prefix="" data-suffix="" style="text-align: center; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">7</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">(b)&nbsp;&nbsp;&nbsp;&nbsp;All notices, requests, consents and other communications hereunder shall be deemed to have been given either (i) if by hand, at the time of the delivery thereof to the receiving party at the address of such party set forth above, (ii) if made by telex, telecopy or facsimile transmission, at the time that receipt thereof has been acknowledged by electronic confirmation or otherwise, (iii) if sent by overnight courier, on the next business day following the day such notice is delivered to the courier service, or (iv) if sent by registered or certified mail, on the 5th business day following the day such mailing is made.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b>12.&nbsp; &nbsp; &nbsp; &nbsp;</b><b><u>Entire Agreement / No Duplication of Compensation or Benefits</u></b><b>. </b>This Agreement, along with any prior employee, non-disclosure and invention agreement entered into between the Executive and the Company, embodies the entire agreement and understanding between the parties hereto with respect to the subject matter hereof and supersedes all prior oral or written agreements and understandings relating to the subject matter hereof. No statement, representation, warranty, covenant or agreement of any kind not expressly set forth in this Agreement shall affect, or be used to interpret, change or restrict, the express terms and provisions of this Agreement. The terms of <u>Sections 2</u> and <u>3</u> above shall replace any agreement, policy or practice which otherwise would obligate the Company to provide any severance compensation and/or benefits to Executive, <i>provided </i>that this provision shall not be construed to otherwise limit Executive&#8217;s rights to payments or benefits provided under any pension plan (as defined in Section 3(2) of the Employee Retirement Income Security Act of 1974, as amended), deferred compensation, stock, stock option or similar plan sponsored by the Company.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b>13.&nbsp;&nbsp; &nbsp; &nbsp; &nbsp;</b><b><u>Modifications and Amendments</u></b><b>. </b>The terms and provisions of this Agreement may be modified or amended only by written agreement executed by all parties hereto.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b>14.&nbsp; &nbsp; &nbsp; &nbsp;&nbsp;</b><b><u>Waivers and Consents</u></b><b>. </b>The terms and provisions of this Agreement may be waived, or consent for the departure therefrom granted, only by written document executed by the party entitled to the benefits of such terms or provisions. No such waiver or consent shall be deemed to be or shall constitute a waiver or consent with respect to any other terms or provisions of this Agreement, whether or not similar. Each such waiver or consent shall be effective only in the specific instance and for the purpose for which it was given, and shall not constitute a continuing waiver or consent.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b>15.</b><b>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp;<u>Assignment</u></b><b>. </b>The rights and obligations under this Agreement may not be assigned by either party hereto without the prior written consent of the other party.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b>16.&nbsp; &nbsp; &nbsp; &nbsp;</b><b><u>Benefit</u></b><b>. </b>All statements, representations, warranties, covenants and agreements in this Agreement shall be binding on the parties hereto and shall inure to the benefit of the respective successors and permitted assigns of each party hereto. Nothing in this Agreement shall be construed to create any rights or obligations except among the parties hereto, and no person or entity shall be regarded as a third-party beneficiary of this Agreement.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="8" data-prefix="" data-suffix="" style="text-align: center; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">8</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b>17.&nbsp; &nbsp; &nbsp; &nbsp;&nbsp;</b><b><u>Governing Law / Jurisdiction / Service of Process</u></b><b>. </b>This Agreement and the rights and obligations of the parties hereunder shall be construed in accordance with and governed by the law of the State of Delaware, without giving effect to the conflict of law principles thereof. Any legal action or proceeding with respect to this Agreement will be brought in the courts of the State of New Hampshire or of the United States of America for the District of New Hampshire. By execution and delivery of this Agreement, each of the parties hereto accepts for itself and in respect of its property, generally and unconditionally, the exclusive jurisdiction of the aforesaid courts. Each of the parties hereto irrevocably consents to the service of process of any of the aforementioned courts in any such action or proceeding by the mailing of copies thereof by certified mail, postage prepaid, to the party at its address set forth in <u>Section 11</u>.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">18.&nbsp; &nbsp; &nbsp; &nbsp; &nbsp;<b><u>Non-disparagement</u></b></p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">You agree not to make any disparaging statements concerning the Company or any of Company Releasees or any of its or their products, product candidates, discovery programs or services, current or former officers, directors, employees or agents. These non-disparagement obligations shall not in any way affect your obligation to testify truthfully in any legal proceeding, or any rights that you may have under the National Labor Relations Act or other federal or state law, including any right that you have to disclose future sexual harassment or sexual assault claims or disputes that have not yet arisen and are afforded continued protection by federal or state law.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b>19.</b><b>&nbsp; &nbsp; &nbsp; &nbsp;&nbsp;&nbsp;<u>Counterparts</u></b><b>. </b>This Agreement may be executed in one or more counterparts, and by different parties hereto on separate counterparts, each of which shall be deemed an original, but all of which together shall constitute one and the same instrument.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt;">IN WITNESS WHEREOF, the parties have executed this Agreement as of the day and year first above written.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; width: 100%;">

		<tr>
			<td style="width: 50%;">&nbsp;</td>
			<td colspan="2" rowspan="1" style="width: 4%;">iCAD, Inc.</td>
			<td style="width: 21%;">&nbsp;</td>
		</tr>
		<tr>
			<td style="width: 50%;">&nbsp;</td>
			<td style="width: 4%;">&nbsp;</td>
			<td style="width: 25%;">&nbsp;</td>
			<td style="width: 21%;">&nbsp;</td>
		</tr>
		<tr>
			<td style="width: 50%;">&nbsp;</td>
			<td style="width: 4%;">By:</td>
			<td style="width: 25%; border-bottom: 1px solid rgb(0, 0, 0);">
			<div><img alt="b04.jpg" src="b04.jpg"></div>
			</td>
			<td style="width: 21%;">&nbsp;</td>
		</tr>
		<tr>
			<td style="width: 50%;">&nbsp;</td>
			<td colspan="2" rowspan="1" style="width: 4%;">Brian Testa</td>
			<td style="width: 21%;">&nbsp;</td>
		</tr>
		<tr>
			<td style="width: 50%;">&nbsp;</td>
			<td style="width: 4%;">&nbsp;</td>
			<td style="width: 25%;">&nbsp;</td>
			<td style="width: 21%;">&nbsp;</td>
		</tr>
		<tr>
			<td style="width: 50%;">&nbsp;</td>
			<td style="width: 4%;">Date:</td>
			<td style="width: 25%; border-bottom: 1px solid rgb(0, 0, 0);">Apr 13, 2023</td>
			<td style="width: 21%;">&nbsp;</td>
		</tr>
		<tr>
			<td style="width: 50%;">&nbsp;</td>
			<td style="width: 4%;">&nbsp;</td>
			<td style="width: 25%;">&nbsp;</td>
			<td style="width: 21%;">&nbsp;</td>
		</tr>
		<tr>
			<td style="width: 50%;">&nbsp;</td>
			<td style="width: 4%;">&nbsp;</td>
			<td style="width: 25%;">&nbsp;</td>
			<td style="width: 21%;">&nbsp;</td>
		</tr>
		<tr>
			<td style="width: 50%;">&nbsp;</td>
			<td colspan="2" rowspan="1" style="width: 4%;">EXECUTIVE: Eric Lonnqvist</td>
			<td style="width: 21%;">&nbsp;</td>
		</tr>
		<tr>
			<td style="width: 50%;">&nbsp;</td>
			<td colspan="2" rowspan="1" style="width: 4%; padding-left: 18pt; border-bottom: 1px solid rgb(0, 0, 0);"><i>Eric Lonnqvist</i></td>
			<td style="width: 21%;">&nbsp;</td>
		</tr>
		<tr>
			<td style="width: 50%;">&nbsp;</td>
			<td style="width: 4%;">&nbsp;</td>
			<td style="width: 25%;">&nbsp;</td>
			<td style="width: 21%;">&nbsp;</td>
		</tr>
		<tr>
			<td style="width: 50%;">&nbsp;</td>
			<td style="width: 4%;">Date:</td>
			<td style="width: 25%; border-bottom: 1px solid rgb(0, 0, 0);">Apr 13, 2023</td>
			<td style="width: 21%;">&nbsp;</td>
		</tr>

</table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="9" data-prefix="" data-suffix="" style="text-align: center; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">9</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;&nbsp;</p>

<div contenteditable="false" data-auto-pgnum="end">&nbsp;</div>

<table border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; width: 100%;">

		<tr>
			<td style="width: 50%;">
			<div><img alt="b01.jpg" src="b01.jpg"></div>
			</td>
			<td style="width: 50%;">
			<div style="text-align: right;"><img alt="b02.jpg" src="b02.jpg"></div>
			</td>
		</tr>

</table>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:12pt;font-variant:normal;text-align:center;margin:0pt 0pt 0pt 24pt;"><b>Chief Financial Officer</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;"><b>About iCAD:</b></p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">iCAD is a global leader in advanced breast cancer detection solutions built on artificial intelligence and delivered through both an on premise and SaaS model that empower radiologists to find cancers earlier while improving reading workflow.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">From the world leader in artificial intelligence for breast imaging, discover the ProFound impact iCAD&#8217;s award-winning portfolio of cancer detection, density assessment, and risk evaluation solutions can have on your reading workflow.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Accuracy accelerated. Detection delivered. Powered by AI.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;"><b>The Role:</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">The Chief Financial Officer (CFO) will be responsible for helping us accelerate our growth and path to profitability.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">The CFO will be a blend of strategist, catalyst, steward and operator. As a strategist, the CFO working with the CEO and Executive Leadership Team, defines the future of the company to enhance business performance and shareholder value. The Strategist provides a financial perspective on innovation and profitable growth, leveraging this perspective to improve risk-awareness, strategic decision-making and performance management integration, as well as translating the expectations of the capital markets into internal business imperatives.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">As a catalyst, the CFO gains business alignment to identify, evaluate and execute strategies, and serves as a business partner to other decision-makers.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">From an operator perspective, efficiency and service levels are the primary areas of focus for the CFO balancing cost and service levels in delivering on the finance organization&#8217;s responsibilities, and adapts finance&#8217;s operating model as necessary. The CFO will lead the finance and accounting teams.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">For stewardship, the CFO focuses on ensuring company compliance with financial reporting and control requirements, accounting, control, risk management and asset preservation.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">The candidate must have a deep understanding of accounting practices, SEC, SOX, GAAP and extensive experience filing the 10-Q. In addition, a deep understanding of regulatory markets, investor relations while navigating and partnering with a public board of directors.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">The role will report to the Chief Executive Officer and can be located anywhere in the US.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;"><b>Responsibilities:</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">&#8226;&nbsp;&nbsp;&nbsp;&nbsp;Strategic Advisor: Serve as a business partner and strategic advisor to the CEO and to other members of the top leadership team. Provide insightful focus on critical business levers to drive growth. Contribute actively to the evolution and execution of strategic and business plans across functions. Work closely with the senior management team to evaluate current and future operating performance with the objective of maximizing shareholder value, maintaining and improving</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">financial flexibility and enhancing the company&#8217;s overall financial position. Provide leadership in the planning and execution of fundraising, including equity financings and all forms of debt as necessary and appropriate.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">&#8226;&nbsp;&nbsp;&nbsp;&nbsp;Financial Leadership: Communicate a clear vision for the company to investors, business partners and employees, enhancing the company&#8217;s credibility with shareholders, analysts, and the financial community. Develop and maintain excellent relationships and effectively represent company interests with shareholders, financial institutions and the investment community. Communicate regularly and clearly to institutional investors and analysts to facilitate proper valuation of corporate equity and debt securities.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt 0pt 0pt 8pt;">98 Spit Brook Road, Suite 100 Nashua, NH 03062</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt 0pt 0pt 8pt;">phone: 603.882.5200&nbsp;&nbsp;&nbsp;&nbsp; toll free: 866.280.2239&nbsp;&nbsp;&nbsp;&nbsp; fax: 603.218.6658</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt 0pt 0pt 8pt;">www.icadmed.com</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">&nbsp;</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; width: 100%;">

		<tr>
			<td style="width: 50%;">
			<div><img alt="b01.jpg" src="b01.jpg"></div>
			</td>
			<td style="width: 50%;">
			<div style="text-align: right;"><img alt="b02.jpg" src="b02.jpg"></div>
			</td>
		</tr>

</table>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">&#8226;&nbsp;&nbsp;&nbsp;&nbsp;Financial Management: Think strategically about how best to leverage the company&#8217;s resources to ensure that it continues to have sufficient access to capital, liquidity and funding sources: equity, debt and other mechanisms as appropriate.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">&#8226;&nbsp;&nbsp;&nbsp;&nbsp;Financial Operations: Lead, manage and direct all financial affairs of the company today and in the future; this includes financial planning, forecasting and budgeting, audit, regulatory filings and compliance, finance operations including billing systems, accounts payable, accounts receivable, SOX compliance and timely close of financial reporting each month. Also ensure the integrity and compliance of all financial and regulatory reporting, controls, systems, policies and procedures.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">&#8226;&nbsp;&nbsp;&nbsp;&nbsp;Team leadership: Provide leadership, mentorship and coaching to the finance organization. Establish an environment of problem solving and improved business practices, attract and retains superior financial talent.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">&#8226;&nbsp;&nbsp;&nbsp;&nbsp;Investor Relations: Serve as a key spokesman for the company to broad constituents, ensuring transparency in communications, while positioning the company effectively to prospective investors.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">&#8226;&nbsp;&nbsp;&nbsp;&nbsp;Relationship Management: Develop long-term relationships and credibility with key external constituencies including external auditors, bankers, investors, shareholders, legal counsel and other advisors.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">&#8226;&nbsp;&nbsp;&nbsp;&nbsp;Risk Management: Interface directly with the Board and Audit Committee of the Board, ensuring they have a clear sense of the overall financial health and potential risk areas of the company. Maintain prudent risk policies and exposures and establish balance sheet management and forecasting discipline.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">&#8226;&nbsp;&nbsp;&nbsp;&nbsp;Planning/Budget: Provide overall leadership to the management reporting, financial planning and budgeting processes. Lead efforts to improve the analytical rigor of the finance team so that business decisions throughout the organization are informed by analytical insight.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;"><b>Competencies:</b></p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tr>
			<td style="width:17pt;">&nbsp;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Proven experience as a Chief Financial Officer, Chief Operating Officer, Controller, Executive responsible for Financial Planning &amp; Analysis or similar role; 7+ years experience in <b>executive leadership </b>positions (preferably within a <b>SAAS </b>company or cancer-related company).</p>
			</td>
		</tr>

</table>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tr>
			<td style="width:17pt;">&nbsp;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Sound understanding of business functions and related budgeting processes such as Product Management and Marketing, Development, Sales, HR, Finance, Marketing, Customer Experience, Content Management, Partnerships etc.</p>
			</td>
		</tr>

</table>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tr>
			<td style="width:17pt;">&nbsp;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Demonstrable competency in <b>strategic planning </b>and business development.</p>
			</td>
		</tr>

</table>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tr>
			<td style="width:17pt;">&nbsp;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Sound judgment and aptitude in <b>decision-making </b>and <b>problem-solving</b>.</p>
			</td>
		</tr>

</table>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tr>
			<td style="width:17pt;">&nbsp;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>BSc/BA in Accounting, Finance, Business Administration </b>or relevant field; MSc/MBA is a plus.</p>
			</td>
		</tr>

</table>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tr>
			<td style="width:17pt;">&nbsp;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Leadership skills, with <b>steadfast resolve </b>and <b>personal integrity</b>.</p>
			</td>
		</tr>

</table>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tr>
			<td style="width:17pt;">&nbsp;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Understanding of advanced business planning and regulatory issues.</p>
			</td>
		</tr>

</table>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tr>
			<td style="width:17pt;">&nbsp;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">A solid grasp of <b>data analysis </b>and <b>performance metrics</b>.</p>
			</td>
		</tr>

</table>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tr>
			<td style="width:17pt;">&nbsp;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Demonstrated ability to <b>communicate, present </b>and <b>influence </b>credibly and effectively at all levels.</p>
			</td>
		</tr>

</table>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tr>
			<td style="width:17pt;">&nbsp;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Excellent <b>mentoring, coaching, leadership </b>and <b>people management </b>skills.</p>
			</td>
		</tr>

</table>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tr>
			<td style="width:17pt;">&nbsp;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Strategic thinking </b>- the ability to understand the business implications of decisions; display an orientation towards growth and demonstrate knowledge of market and competition.</p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;"><b>You</b>&#8217;<b>re able to demonstrate:</b></p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">&#8226;&nbsp;&nbsp;&nbsp;&nbsp;A record of executive leadership, ideally of multi-faceted, dynamic, and growth-oriented organizations. Ideally this experience would include functioning for a significant period as the CFO of a publicly traded company.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt 0pt 0pt 8pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt 0pt 0pt 8pt;">98 Spit Brook Road, Suite 100 Nashua, NH 03062</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt 0pt 0pt 8pt;">phone: 603.882.5200&nbsp;&nbsp;&nbsp;&nbsp; toll free: 866.280.2239&nbsp;&nbsp;&nbsp;&nbsp; fax: 603.218.6658</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt 0pt 0pt 8pt;">www.icadmed.com</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">&nbsp;</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; width: 100%;">

		<tr>
			<td style="width: 50%;">
			<div><img alt="b01.jpg" src="b01.jpg"></div>
			</td>
			<td style="width: 50%;">
			<div style="text-align: right;"><img alt="b02.jpg" src="b02.jpg"></div>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">&#8226;&nbsp;&nbsp;&nbsp;&nbsp;Professional stature and a record of organizational impact, both within the finance function across all functions as a tenured member of senior leadership teams.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#8226;&nbsp; &nbsp; Credibility within the investment community; broad experience in the structuring and implementing of various financial&nbsp;and business transactions including capital raising.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">&#8226;&nbsp; &nbsp;&nbsp;Expertise within diagnostics, and an ability to grasp and articulate scientific concepts. Recent leadership experience in a&nbsp;dynamic and growth-oriented organization is ideal.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">&#8226;&nbsp;&nbsp;&nbsp;&nbsp;Experience from within established, disciplined, successful organizations; recent leadership within a company that has scaled from discovery through to late stage clinical development.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">&#8226;&nbsp;&nbsp;&nbsp;&nbsp;A demonstrated track record of serving as a business partner to the CEO, the Board and the senior leadership team with the ability to influence key business decisions and track performance against key objectives.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#8226;&nbsp; &nbsp;&nbsp;An energetic, positive, ambitious and communicative executive who maintains transparency both internally and&nbsp;externally. Excellent interpersonal communications, public speaking, and presentation skills.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#8226;&nbsp; &nbsp;&nbsp;A desire to work with purpose and passion; demonstrates tenacity and works towards continuous improvement.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#8226;&nbsp; &nbsp;&nbsp;A team orientation. Someone who focuses on collective results rather than individual achievements.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#8226;&nbsp; &nbsp;&nbsp;The highest ethics and moral standards; unquestioned integrity.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#8226;&nbsp; &nbsp;&nbsp;Outstanding intellectual ability with judgment that reflects reasoned and creative business views.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">&#8226;&nbsp;&nbsp;&nbsp;&nbsp;A broad-minded and practical business-minded individual who can grasp the impact of financial and operating decisions to the overall strategy.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">&#8226;&nbsp;&nbsp;&nbsp;&nbsp;A well-organized, high energy, detail-oriented, and persistent executive with the ability to identify/focus on key issues, prioritize efforts, and ensure follow up with timely/quality results.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;"><b>This Job might be for you if:</b></p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tr>
			<td style="width:17pt;">&nbsp;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">You are a <b>team player</b>. You understand that flying solo is a limiting and isolating choice and know that making your team look good works far better than creating a one-man show.</p>
			</td>
		</tr>

</table>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tr>
			<td style="width:17pt;">&nbsp;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">You are an expert <b>communication </b>router - being at the center of the information triangle among market, team and company, you know how to find the best method and style to communicate thoughts, ideas, and feedback.</p>
			</td>
		</tr>

</table>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tr>
			<td style="width:17pt;">&nbsp;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">You <b>lead by influence </b>and <b>example</b>, through <b>motivating, guiding </b>and keeping your functional leads <b>focused </b>on the vision and goals.</p>
			</td>
		</tr>

</table>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tr>
			<td style="width:17pt;">&nbsp;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">You relate well to people and <b>easily establish good relationships</b>.</p>
			</td>
		</tr>

</table>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tr>
			<td style="width:17pt;">&nbsp;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">You respond quickly and appropriately to the needs of others.</p>
			</td>
		</tr>

</table>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tr>
			<td style="width:17pt;">&nbsp;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">You have a knack for <b>explaining complicated things simply.</b></p>
			</td>
		</tr>

</table>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tr>
			<td style="width:17pt;">&nbsp;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">You&#8217;re <b>level-headed </b>and <b>cool under pressur</b>e. When things change, you know how to roll with the punches.</p>
			</td>
		</tr>

</table>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tr>
			<td style="width:17pt;">&nbsp;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">You can tolerate <b>ambiguity</b>.</p>
			</td>
		</tr>

</table>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tr>
			<td style="width:17pt;">&nbsp;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">You enjoy managing the <b>big picture</b>, as well as the <b>small details.</b></p>
			</td>
		</tr>

</table>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tr>
			<td style="width:17pt;">&nbsp;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">You are an <b>out-the-box thinker </b>when it comes to finding solutions for problems.</p>
			</td>
		</tr>

</table>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tr>
			<td style="width:17pt;">&nbsp;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Basically, you will blow us away with your <b>work ethic</b>, your passion, your <b>integrity</b>, your <b>attitude </b>and your <b>energy!</b></p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;"><b>You</b>&#8217;<b>re good at:</b></p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tr>
			<td style="width:17pt;">&nbsp;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Project Management</p>
			</td>
		</tr>

</table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt 0pt 0pt 8pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt 0pt 0pt 8pt;">98 Spit Brook Road, Suite 100 Nashua, NH 03062</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt 0pt 0pt 8pt;">phone: 603.882.5200&nbsp;&nbsp;&nbsp;&nbsp; toll free: 866.280.2239&nbsp;&nbsp;&nbsp;&nbsp; fax: 603.218.6658</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt 0pt 0pt 8pt;">www.icadmed.com</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">&nbsp;</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; width: 100%;">

		<tr>
			<td style="width: 50%;">
			<div><img alt="b01.jpg" src="b01.jpg"></div>
			</td>
			<td style="width: 50%;">
			<div style="text-align: right;"><img alt="b02.jpg" src="b02.jpg"></div>
			</td>
		</tr>

</table>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tr>
			<td style="width:17pt;">&nbsp;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Problem-Solving &amp; Analytical Thinking</p>
			</td>
		</tr>

</table>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tr>
			<td style="width:17pt;">&nbsp;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Staying sharp with technology and having a holistic view of technologies around you.</p>
			</td>
		</tr>

</table>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tr>
			<td style="width:17pt;">&nbsp;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Public speaking</p>
			</td>
		</tr>

</table>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tr>
			<td style="width:17pt;">&nbsp;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Leadership &amp; Teamwork</p>
			</td>
		</tr>

</table>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tr>
			<td style="width:17pt;">&nbsp;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Prioritization</p>
			</td>
		</tr>

</table>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tr>
			<td style="width:17pt;">&nbsp;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Process building. You use Continuous Improvement tools (such as Lean, Six Sigma, Agile etc.) to improve processes, tech, people and systems.</p>
			</td>
		</tr>

</table>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tr>
			<td style="width:17pt;">&nbsp;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Structuring new teams</p>
			</td>
		</tr>

</table>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tr>
			<td style="width:17pt;">&nbsp;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Leading, managing and motivating people &amp; teams</p>
			</td>
		</tr>

</table>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tr>
			<td style="width:17pt;">&nbsp;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Coaching &amp; developing staff</p>
			</td>
		</tr>

</table>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tr>
			<td style="width:17pt;">&nbsp;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Setting appropriate standards of performance &amp; behavior</p>
			</td>
		</tr>

</table>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tr>
			<td style="width:17pt;">&nbsp;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Performance Management</p>
			</td>
		</tr>

</table>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tr>
			<td style="width:17pt;">&nbsp;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Persuading &amp; Influencing</p>
			</td>
		</tr>

</table>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tr>
			<td style="width:17pt;">&nbsp;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Networking &amp; collaborating with others</p>
			</td>
		</tr>

</table>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tr>
			<td style="width:17pt;">&nbsp;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Planning &amp; organizing</p>
			</td>
		</tr>

</table>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tr>
			<td style="width:17pt;">&nbsp;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Implementing operational business plans to meet business needs</p>
			</td>
		</tr>

</table>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tr>
			<td style="width:17pt;">&nbsp;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Process design, implementation &amp; management</p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">iCAD is an Equal Opportunity Employer and values diversity. We are committed to the principles of equal employment opportunity and affirmative action for all applicants and employees. Equal opportunity and consideration are afforded to all qualified applicants and employees in personnel actions, which include recruiting and hiring, selection for training, promotion, rates of pay or other compensation, transfer, discipline, demotion, layoff or termination. ICAD does not unlawfully discriminate on the basis of race, color, religion, sexual orientation, marital status, pregnancy, gender identity, gender expression, family medical history or genetic information, citizenship, national origin or ancestry, sex, age, physical or mental disability, medical condition, veteran status, military status, or any other basis protected by federal, state or local law, ordinance or regulation.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; width: 100%;">

		<tr>
			<td style="width: 5%;">&nbsp;</td>
			<td style="width: 42%; border-bottom: 1px solid rgb(0, 0, 0); text-align: center;"><i>Eric Lonnqvist</i></td>
			<td style="width: 6%;">&nbsp;</td>
			<td style="width: 42%; border-bottom: 1px solid rgb(0, 0, 0); text-align: center;">Apr 13, 2023</td>
			<td style="width: 5%;">&nbsp;</td>
		</tr>
		<tr>
			<td style="width: 5%;">&nbsp;</td>
			<td style="width: 42%; text-align: center;">Eric Lonnqvist</td>
			<td style="width: 6%;">&nbsp;</td>
			<td style="width: 42%; text-align: center;">Date</td>
			<td style="width: 5%;">&nbsp;</td>
		</tr>

</table>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt 0pt 0pt 8pt;">98 Spit Brook Road, Suite 100 Nashua, NH 03062</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt 0pt 0pt 8pt;">phone: 603.882.5200&nbsp;&nbsp;&nbsp;&nbsp; toll free: 866.280.2239&nbsp;&nbsp;&nbsp;&nbsp; fax: 603.218.6658</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt 0pt 0pt 8pt;">www.icadmed.com</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">&nbsp;</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<div contenteditable="false" data-applyto="t" data-auto-pgnum="start" data-displaynum="1" data-fontname="Times New Roman" data-fontsize="10pt" data-numstyle="a" data-prefix="" data-startnum="1" data-suffix="." data-textalign="center">&nbsp;</div>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt 0pt 0pt 24pt;"><b>iCAD, Inc.</b></p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt 0pt 0pt 24pt;"><b>Confidentiality, Invention Assignment and Non-Solicitation Agreement</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">In consideration of employment of the undersigned (&#8220;Employee&#8221;) by or on behalf of iCAD, Inc. or its subsidiary (the &#8220;Company&#8221;), Employee covenants and agrees:</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 18pt;">&nbsp;</td>
			<td style="width: 18pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;"><b>1.</b></p>
			</td>
			<td style="width: auto;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b>ACKNOWLEDGEMENTS AND EMPLOYEE ACCESS TO CONFIDENTIAL INFORMATION</b>.&nbsp;Employee acknowledges that: (a) Company is in a highly competitive industry; (b) from the outset of and during the course of Employee&#8217;s employment with Company Employee will have access to Confidential Information (as such term is defined below) of Company and/or its client relationships and goodwill, which, are highly valuable to Company and if disclosed in an unauthorized manner, could be highly prejudicial to Company and/or its clients; (c) Company would be irreparably harmed by Employee&#8217;s subsequent work for a competitor due to the possibility that there would be inadvertent or other disclosures of Company&#8217;s to Confidential Information (as such term is defined below) or that there would be improper interference with its valuable client relationships and goodwill; (d) Employee was given adequate consideration for this Agreement, and that as additional consideration for signing this Agreement and the restrictions contained herein, Employee acknowledges that Employee was given access to Confidential Information (as such term is defined below), proprietary and trade secret information; and (e) the restrictions in this Agreement are reasonable and necessary to protect the Company&#8217;s legitimate business interests.</p>
			</td>
		</tr>

</table>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 65pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 18pt;">&nbsp;</td>
			<td style="width: 18pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;"><b>2.</b></p>
			</td>
			<td style="width: auto;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b>VALUE OF COMPANY BUSINESS, CLIENTS, AND CONFIDENTIAL INFORMATION</b>. Employee&nbsp;acknowledges that Company has created and developed Confidential Information (as such term is defined below). Additionally, Employee acknowledges that Company has entered into agreements with third parties whereby these third parties produce confidential, proprietary, and/or trade secret information for Company. Such information has independent actual or potential economic value from not being generally known to the public or to other persons who can obtain economic value from its disclosure or use, and is not readily available through any source other than Company. Maintenance of confidentiality regarding such information and special knowledge is essential to preserving the competitive position and value of Company. Further, the specialized services provided by Company to its clients are such that potential clients might not be aware of the availability of such services from Company. This specialized business requires Company to develop confidential relationships with its clients, whereby Company and each client work together closely to develop customized services for each client. Therefore, information concerning both the nature and the fact that Company's client relationships has independent actual or potential economic value from not being generally known to the public or to other persons who can obtain economic value from its disclosure or use.</p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 18pt;">&nbsp;</td>
			<td style="width: 18pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;"><b>3.</b></p>
			</td>
			<td style="width: auto;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b>CONFIDENTIAL INFORMATION DEFINED</b>. &#8220;Confidential Information&#8221;&nbsp;of Company includes, but is not limited to, proprietary and trade secret information; the identity of Company clients; client information, including without limitation, personal, financial, social, or business information, client lists, client addresses or phone numbers, client contracts, particular needs and preferences of each client, and the manner in which business is conducted with each client; business methods; devices; processes; compilation of information; computer software developed by or for Company; computer-aided cancer detection methods; records; sales techniques and figures; marketing strategies; pricing and pricing strategies; methods of data processing; codes; surveys; designs; questionnaires; reports; industry norms; models; forecasts; formulae; equations; studies or data developed in connection with any project or activity of Company, and Company financial information.</p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 54pt;">&nbsp;</td>
			<td style="width: 18pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">a.</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">Confidential Information shall not include: (a) information now and hereafter voluntarily disseminated by Company to the public or which otherwise becomes part of the public domain through lawful means; and (b) information already known to Employee as documented by written records which predate Employee's employment with Company.</p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 18pt;">&nbsp;</td>
			<td style="width: 18pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;"><b>4.</b></p>
			</td>
			<td style="width: auto;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b>NON-DISCLOSURE OF CONFIDENTIAL INFORMATION. </b>The Employee shall not, during or after Employee's employment with Company, use, publish, communicate, reproduce, disclose, remove from Company premises, or disseminate in any manner whatsoever any Confidential Information, either directly or indirectly, except as required in the course of employment with Company, as expressly authorized in writing by an officer or manager of Company, or as is disclosed as part of a voluntary&nbsp;communication with the United States Securities and Exchange Commission or any other governmental agency about a good-faith belief that a securities law violation may have occurred. Nothing in this Agreement shall waive or release any rights or claims that Employee may have under the Dodd-Frank Wall Street Reform and Consumer Protection Act. Nothing in this Agreement prohibits Employee from discussing terms and conditions of employment or engaging in other concerted activity protected by law. Further, nothing in this Agreement prohibits Employee from cooperating with governmental investigations or reporting possible violations of laws or regulations to any governmental agency or entity, as required by law.</p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Non-California Employees</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="1" data-prefix="" data-suffix="." style="text-align: center; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">1.</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 18pt;">&nbsp;</td>
			<td style="width: 18pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;"><b>5.</b></p>
			</td>
			<td style="width: auto;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b>DUTY TO PREVENT DISCLOSURE. </b>Employee agrees to take all precautions reasonably necessary to prevent the unauthorized handling, use, access, disclosure, or dissemination of Confidential Information either during employment with Company or following termination of employment with Company for any reason whatsoever and Employee shall follow all applicable policies and procedures of the Company regarding maintenance and protection of Confidential Information.</p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 18pt;">&nbsp;</td>
			<td style="width: 18pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;"><b>6.</b></p>
			</td>
			<td style="width: auto;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b>CLIENT INFORMATION</b>. Employee agrees not to use, publish, communicate, reproduce, disclose, remove from Company premises, or disseminate in any manner whatsoever, for compensation or otherwise, any information, actions, events, behavior, or other conduct that Employee observes or hears from Company&#8217;s clients, either directly or indirectly, either during employment with Company or following termination of employment, except as required in the course of employment with Company.</p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 18pt;">&nbsp;</td>
			<td style="width: 18pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;"><b>7.</b></p>
			</td>
			<td style="width: auto;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b>REQUIRED DISCLOSURE. </b>Notwithstanding Sections 4, 5 and 6 above, in the event that Employee is requested or required (by oral questions, interrogatories, requests for information or documents, subpoena, civil investigative demand or other similar process in legal proceedings) to disclose any of the Confidential Information, Employee shall provide Company with prompt written notice of any such request or requirement so that Company may seek a protective order or other appropriate remedy, or waive compliance with the provisions of this Agreement.</p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 18pt;">&nbsp;</td>
			<td style="width: 18pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;"><b>8.</b></p>
			</td>
			<td style="width: auto;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b>RETURN OF MATERIALS UPON TERMINATION OF EMPLOYMENT. </b>Employee agrees that upon termination of Employee's employment with Company, for any reason whatsoever, Employee will immediately turn over to Company all Confidential Information, including but not limited to, any client lists, client contracts, or other client information in Employee's possession. Employee also agrees that upon Employee&#8217;s termination of employment with Company, for any reason whatsoever, to return all other Company property or equipment, including but not limited to documents, computer software, and/or other materials related to the business, professional or personal affairs of Company or any of Company&#8217;s clients. Further, Employee will not retain any copies of any of the above materials in hardcopy, electronic or other form.</p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 18pt;">&nbsp;</td>
			<td style="width: 18pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;"><b>9.</b></p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;"><b>INVENTIONS.</b></p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 54pt;">&nbsp;</td>
			<td style="width: 18pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">a.</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">Employee has attached hereto, as Exhibit A, a list describing all inventions, original works of authorship, developments, improvements, and trade secrets which were made by him/her prior to his/her employment with the Company (collectively referred to as &#8220;Prior Inventions&#8221;), which belong to him/her, which relate to the Company&#8217;s proposed business, products or research and development, and which are not assigned to the Company hereunder; or, if no such list is attached, Employee represents that there are no such Prior Inventions. If in the course of Employee&#8217;s employment with the Company, Employee incorporates into a Company product, process or service a Prior Invention owned by him/her or in which Employee has an interest, Employee hereby grants to the Company a nonexclusive, royalty-free, fully paid-up, irrevocable, perpetual, worldwide license to make, have made, modify, use and sell such Prior Invention as part of or in connection with such product, process or service, and to practice any method related thereto.</p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 54pt;">&nbsp;</td>
			<td style="width: 18pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">b.</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">Employee will promptly disclose to the Company, or any persons designated by it, all improvements, inventions, original works of authorship, developments, concepts, designs, discoveries, ideas, trademarks, trade secrets, formulae, processes, techniques, know-how and data, whether or not patentable or copyrightable, made or conceived or reduced to practice or learned by Employee, either alone or jointly with others, during the period of Employee's employment hereunder, which are related to or useful in the business of the Company, or&nbsp;result from tasks assigned Employee by the Company, or result from use of premises owned, leased or contracted for by the Company collectively referred to herein as "Inventions"), except as provided in section 8.f below.</p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Non-California Employees</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="2" data-prefix="" data-suffix="." style="text-align: center; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">2.</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 54pt;">&nbsp;</td>
			<td style="width: 18pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">c.</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">Employee agrees that all Inventions shall be the sole property of the Company and its assigns, and the Company and its assigns shall be the sole owner of all patents and other rights in connection therewith. Employee hereby assigns to the Company any rights Employee may have or acquire in all Inventions. Employee further agrees, as to all Inventions, to assist the Company in every proper way (but at the Company's expense) to obtain and from time to time enforce patents and copyrights on and trade secrets relating to Inventions in any and all countries, and to that end Employee will execute all documents for use in applying for and obtaining such patents and copyrights thereon and enforcing same, as the Company may desire, together with any assignments thereof to the Company or persons designated by it.</p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 54pt;">&nbsp;</td>
			<td style="width: 18pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">d.</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">Employee's obligation to assist the Company in obtaining and enforcing patents and copyrights for and trade secrets relating to Inventions in any and all countries shall continue beyond the termination of Employee's employment, but the Company shall compensate Employee at a reasonable rate after such termination for time actually spent by Employee at the Company's request on such assistance.</p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 54pt;">&nbsp;</td>
			<td style="width: 18pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">e.</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">Employee agrees to keep and maintain adequate and current written records of all Inventions made by him/her (solely or jointly with others) during the term of his/her employment with the Company. The records will be in the form of notes, sketches, drawings, and any other format that may be specified by the Company. The records will be available to and remain the sole property of the Company at all times.</p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 18pt;">&nbsp;</td>
			<td style="width: 18pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;"><b>10.</b></p>
			</td>
			<td style="width: auto;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b>THIRD PARTY INFORMATION. </b>Employee acknowledges and agrees that Employee will not utilize any confidential, proprietary or trade secret information of any other party in Employee's work for the Company, will not knowingly infringe on the patent, copyright or trademark of any other party in Employee's work for the Company, and is not bound or restricted in Employee's work for the company as a result of any non-competition or other agreement or agreements to which Employee is bound.</p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 18pt;">&nbsp;</td>
			<td style="width: 18pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;"><b>11.</b></p>
			</td>
			<td style="width: auto;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b>PROHIBITION ON USE OF TRADE SECRET INFORMATION TO SOLICIT CLIENTS</b>. Employee&nbsp;agrees that during his/her employment with Company and following termination of Employee's employment with Company, for any reason whatsoever, Employee shall not use any Company trade secrets to contact or solicit any clients or prospective clients of Company whom he/she served or whose names became known to him/her while in the employ of Company either on the Employee's behalf or on behalf of any other party engaged in a business which is competitive with Company.</p>
			</td>
		</tr>

</table>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 65pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 18pt;">&nbsp;</td>
			<td style="width: 18pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;"><b>12.</b></p>
			</td>
			<td style="width: auto;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b>NON-SOLICITATION OF COMPANY EMPLOYEES</b>. Employee agrees that during his/her employment with Company and for a period of one year following termination of his/her employment with Company, Employee shall refrain from interfering with Company's employees and shall not directly or indirectly, recruit or attempt to recruit, solicit or attempt to solicit, induce or attempt to induce, persuade or attempt to persuade any Company employee to leave the service of Company, whether or not the solicited employee would commit any breach of his or her own employment terms by so leaving.</p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 18pt;">&nbsp;</td>
			<td style="width: 18pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;"><b>13.</b></p>
			</td>
			<td style="width: auto;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b>NO COMPETITION DURING EMPLOYMENT. </b>Employee agrees that during his/her employment with Company, Employee will not engage in any other employment or activity that might interfere with or be in competition with the interests of Company.</p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 18pt;">&nbsp;</td>
			<td style="width: 18pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;"><b>14.</b></p>
			</td>
			<td style="width: auto;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b>NON-COMPETE AFTER EMPLOYMENT. </b>Employee agrees that for a period one year following the termination of his/her employment with Company (&#8220;Restrictive Period&#8221;), he/she will not, directly or indirectly work for a business directly competitive with the Company within the United States of America. This means Employee will not engage in any activities involving computer-aided detection or diagnosis or treatment of cancer or other conditions as an employee, owner, investor, independent contractor, or consultant during the Restrictive Period.</p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">Non-California Employees</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="3" data-prefix="" data-suffix="." style="text-align: center; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">3.</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 18pt;">&nbsp;</td>
			<td style="width: 18pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;"><b>15.</b></p>
			</td>
			<td style="width: auto;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b>REMEDIES. </b>In the event Employee breaches any of the covenants contained herein, Employee acknowledges that the Company&#8217;s remedy at law for damages will be inadequate and that a breach may cause irreparable injury to Company that could not be compensated by money damages. Therefore Company may enforce this Agreement by seeking injunctive relief, obtain a court order prohibiting Employee from breaching the Agreement and seek to recover any and all costs and expenses incurred in enforcing this Agreement, in addition to any other relief provided by applicable law. The limitations in this Agreement, which apply for a period one year after termination, shall be enforced by a court from the date of the last breach or violation of the applicable restriction(s) up to twenty-four months after termination of employment.</p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 18pt;">&nbsp;</td>
			<td style="width: 18pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;"><b>16.</b></p>
			</td>
			<td style="width: auto;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b>TRADE SECRETS. </b>The Parties further recognize and acknowledge that neither the above provisions nor Company's exercise of any rights thereunder shall limit the rights of Company under applicable statutes and common law rules regarding trade secrets or limit the rights of Company to seek damages relief.</p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 18pt;">&nbsp;</td>
			<td style="width: 18pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;"><b>17.</b></p>
			</td>
			<td style="width: auto;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b>TERMINATION OF EMPLOYEE. </b>Violation by Employee of any of these provisions shall, in addition to any other remedy available to Company, be sufficient basis for immediate termination of Employee as an employee of the Company.</p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 18pt;">&nbsp;</td>
			<td style="width: 18pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;"><b>18.</b></p>
			</td>
			<td style="width: auto;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b>SEVERABILITY AND REFORMATION</b>. The parties agree that in the event a court of competent jurisdiction finds any provision of this Agreement to be invalid or otherwise unenforceable, the remaining portions of this Agreement will retain their full force and effect. If a court decides that any provision of this Agreement is too broad, then the court may limit and/or reform that provision and enforce it as limited and/or reformed.</p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 18pt;">&nbsp;</td>
			<td style="width: 18pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;"><b>19.</b></p>
			</td>
			<td style="width: auto;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b>ENTIRE AND SOLE AGREEMENT</b>. The parties agree that this Agreement contains their entire agreement and supersedes all other agreements and understandings, whether written or oral, covering the subject matter hereof. The parties warrant that there were no representations, agreements, arrangements or understandings, whether written or oral, between them relating to the subject matter contained in this Agreement which are not fully expressed herein. No modification, amendment or waiver of any of the provisions contained in this Agreement, or any future representations, promise, or condition in connection with the subject matter of this Agreement, shall be binding upon any party to this Agreement unless made in writing and signed by such party or by a duly authorized officer, partner, or agent of such party.</p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 18pt;">&nbsp;</td>
			<td style="width: 18pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;"><b>20.</b></p>
			</td>
			<td style="width: auto;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b>CHOICE OF LAW AND FORUM</b>. The parties agree that the laws of the State of New Hampshire shall govern the interpretation and enforcement of this Agreement, without giving effect to that state's choice of law rules and shall exclusively be enforced by any state or federal court of the State of New Hampshire, and the parties to this Agreement consent to the jurisdiction and venue of New Hampshire.</p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 18pt;">&nbsp;</td>
			<td style="width: 18pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;"><b>21.</b></p>
			</td>
			<td style="width: auto;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b>INDEPENDENT REVIEW AND ADVICE</b>. By signing his/her name below, Employee expressly acknowledges that he/she has read this Agreement, has had the opportunity to ask Company representatives questions about it, has had the opportunity to consult with an attorney of his/her choice (at his/her own expense) before signing it, and understands the contents of this Agreement. Employee further agrees that signing this Agreement is a condition of his/her employment with Company and payment therefore, which he/she understood before accepting employment with Company.</p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 18pt;">&nbsp;</td>
			<td style="width: 18pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;"><b>22.</b></p>
			</td>
			<td style="width: auto;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b>COSTS AND ATTORNEYS FEES. </b>In the event of any dispute, controversy, or other proceedings (including litigation or arbitration) arising out of or related to this Agreement, the prevailing party shall be entitled to reimbursement of all of its costs, including without limitation attorney and expert witness fees and costs.</p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 18pt;">&nbsp;</td>
			<td style="width: 18pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;"><b>23.</b></p>
			</td>
			<td style="width: auto;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b>SUCCESSORS AND ASSIGNS</b>. All covenants, representations, warranties and agreements of the parties contained herein shall be binding upon and inure to the benefit of their respective successors&nbsp;and permitted assigns.</p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 65pt;">&nbsp;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">Non-California Employees</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="4" data-prefix="" data-suffix="." style="text-align: center; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">4.</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;"><b>EMPLOYEE SIGNATURE:&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;&nbsp;</b><i><u>Eric Lonnqvist</u></i><u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</u></p>

<hr style="height: 1px; color: #000000; background-color: #000000; width: 100%; border: none; margin: 3pt 0">
<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;"><b>YOUR NAME PRINTED:&nbsp; &nbsp; &nbsp; &nbsp; &nbsp;</b>Eric Lonnqvist</p>

<hr style="height: 1px; color: #000000; background-color: #000000; width: 100%; border: none; margin: 3pt 0">
<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 85pt;">&nbsp;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;"><b>DATE:&nbsp; &nbsp; &nbsp; &nbsp; </b>Apr 13, 2023<b>&nbsp; &nbsp; &nbsp;</b></p>

<hr style="height: 1px; color: #000000; background-color: #000000; width: 100%; border: none; margin: 3pt 0">
<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">Non-California Employees</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="5" data-prefix="" data-suffix="." style="text-align: center; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">5.</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<div contenteditable="false" data-auto-pgnum="end">&nbsp;</div>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 12pt; font-variant: normal; text-align: center; margin: 0pt;"><b>iCAD, Inc.</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 12pt; font-variant: normal; text-align: center; margin: 0pt;"><b>POLICY </b></p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 12pt; font-variant: normal; text-align: center; margin: 0pt;"><b>STATEMENT ON</b></p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 12pt; font-variant: normal; text-align: center; margin: 0pt;"><b>TRADING IN iCAD, INC. </b></p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 12pt; font-variant: normal; text-align: center; margin: 0pt;"><b>SECURITIES BY DIRECTORS, </b></p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 12pt; font-variant: normal; text-align: center; margin: 0pt;"><b>OFFICERS, CONSULTANTS </b></p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 12pt; font-variant: normal; text-align: center; margin: 0pt;"><b>AND OTHER EMPLOYEES</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Because the Common Stock of iCAD, inc. (the "Company") is publicly traded, all directors and employees must be aware of and scrupulously observe the various laws and rules prohibiting what is commonly referred to as "insider trading." This Policy Statement is designed to protect the Company's reputation for integrity and ethical conduct that we have all worked hard to achieve. The policy applies to all directors, officers, consultants and other employees of the Company. It also affects members of your family as well as your friends and associates. Consultants of the Company also are expected to abide by all aspects of this policy.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 9pt;">At the outset, it should be made clear that an investment in the Company's publicly traded securities by directors, officers, employees and persons associated with the Company is encouraged. Nonetheless, it is also important to advise you of certain restrictions on purchases or sales as required under the securities laws. The securities laws are comprehensive and far reaching. Accordingly, this Policy Statement is primarily concerned with insider trading, points out only the more common problems relevant to that subject and does not attempt to deal with all of the prohibitions and restrictions which may be applicable to transactions in securities by a director or employee of the Company or his or her relatives. <u>Specific </u> <u>questions should be addressed to the Chief Financial Officer of the Company.</u></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 9pt;"><b><u>Failure to comply with this Policy Statement may result in the loss of your job as</u></b><b> </b><b><u>well as substantial civil and criminal penalties.</u></b><b> </b>Please read this Policy Statement carefully and keep it in your files for future reference. We ask that you return the attached certification to the Company's HR or Personnel department after you have read this Policy Statement. The Company may require you to confirm to the Company from time to time that you have reviewed this Policy Statement and are in compliance.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">&nbsp;</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><b>POLICY</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 9pt;">It is the Company's policy that a director, officer or other employee (or a related person) who has material, non-public information relating to the Company may not buy or sell securities of the Company or engage in any other action to take advantage of, or pass on to others, that information. This policy also applies to non- public information about any other company that is obtained in the course of your employment. However, this policy does not apply to transactions directly with the Company, including, without limitation, purchases of stock upon exercises of stock options or other convertible securities issued by the Company or transactions pursuant to a pre-approved trading plan that complies with Rule lObS-1 of the Securities Exchange Act of 1934. The policy does apply, however, to any sale of stock as part of a broker-assisted "cashless" exercise of an option or warrant or other convertible security, or any other sale of the Company's stock for the purpose of generating the cash needed to pay the exercise price of an option or warrant or other convertible security.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">&nbsp;</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 9pt;">The following transactions are <u>PROHIBITED </u>for directors, officers, consultants and other employees (or related persons) (even if you are not in the possession of material, non-public information):</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 27pt;">&nbsp;</td>
			<td style="width: 18pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">1.</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">Buying or selling the Company's stock during "blackout periods", except for purchases of stock from the Company (such as the exercise of stock options or warrants or other convertible securities) or sales of stock made to the Company or purchases or sales of stock made pursuant to a pre-approved trading plan that complies with Rule lObS-1 of the Securities Exchange Act of 1934. The blackout period begins on the 15</p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 27pt;">&nbsp;</td>
			<td style="width: 18pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">2.</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">"Short" sales of the Company's stock (i.e., where a person borrows the Company's stock, sells it and then buys the Company's stock at a later date to replace the borrowed shares).</p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 27pt;">&nbsp;</td>
			<td style="width: 18pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">3.</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">Buying or selling puts or calls of the Company's shares. A put is an option or right to sell a specific stock at a specific price prior to a set date, and a call is an option or right to buy a specific stock at a specific price prior to a set date. Call options are purchased when a person believes that the price of a stock will rise, while put options are purchased when a person believes that the price of a stock will fall.</p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 27pt;">&nbsp;</td>
			<td style="width: 18pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">4.</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">Purchasing Company shares on margin (i.e., paying less than 100% of the purchase price for the securities before receiving full ownership of the securities).</p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 27pt;">&nbsp;</td>
			<td style="width: 18pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">5.</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">Short-term trading in securities (i.e., securities held for less than six months), other than the sale of securities underlying an exercised option, warrant or other convertible security that has been held for more than six months. This restriction already applies to directors and executive officers and is now being extended to all employees.</p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 27pt;">In addition, the Company may, from time to time, issue instructions advising designated personnel that they may not for designated periods buy or sell securities of the Company, or that no such securities may be traded without the prior approval of the officer or officers designated in such notice.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 27pt;">Transactions that may be necessary for independent reasons (such as the need to raise money for an emergency) are no exceptions. Even the appearance of an improper transaction must be avoided. Directors, officers and other employees are responsible for ensuring that members of their household and their immediate families comply with this policy.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">&nbsp;</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;"><b>QUESTIONS AND ANSWERS RELATED</b></p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;"><b>TO THE INSIDER TRADING POLICY</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;"><b><u>What is Insider Trading?</u></b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 27pt;">Generally, insider trading occurs when a person buys or sells the Company's securities while in the possession of material, non-public information about the Company. Insider trading is not confined to the Company's securities. If, for example an employee learns that a contract is about to be entered into with another public company, trading in the securities of that other company also is prohibited if the information is material to that company and not yet disclosed to the public.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 27pt;">Liability also can occur if this kind of information is passed on to a person (a practice know as "tipping") who then trades in the security. Intent generally is not relevant. A casual comment made to another person could be a "tip," even without knowledge of intent that the other person will trade in the securities. In essence, being in possession of material inside information imposes an obligation not to disclose that information to an unauthorized person. This non- disclosure obligation is in addition to any confidentiality responsibilities you may have to the Company.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;"><b><u>Who is an Insider?</u></b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 27pt;">Any person (directors, officers, other employees and non-employees alike) who is in possession of material, non-public information is an "insider" for purposes of these restrictions.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;"><b><u>What is Material Information?</u></b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 27pt;">Information which is material, as used in this context, is any fact or circumstance which, if known to a responsible investor, would have a reasonable likelihood of influencing the decision to invest or to sell. Both good and bad news can be material, and information may be material even though it would not be sufficient to change the investor's decision. It is sufficient that the information would be significant as part of the total mix of information available to an insider, for purposes of making a decision. In simple terms, material information is anything that is likely to affect the price of the stock. Examples of material information include:</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 54pt;">&nbsp;</td>
			<td style="width: 27pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">(i)</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">the proposed acquisition of a significant business;</p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 54pt;">&nbsp;</td>
			<td style="width: 27pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">(ii)</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">a significant expansion or cutback of operations;</p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 54pt;">&nbsp;</td>
			<td style="width: 27pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">(iii)</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">internal financial information that departs from what the market would expect;</p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 54pt;">&nbsp;</td>
			<td style="width: 27pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">(iv)</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">a default or anticipated default under debt instruments or important contracts;</p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 54pt;">&nbsp;</td>
			<td style="width: 27pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">(v)</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">a proposal for a merger or the purchase or sale of substantial assets;</p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">&nbsp;</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 54pt;">&nbsp;</td>
			<td style="width: 27pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">(vi)</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">a tender offer for the shares of the Company's securities;</p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 54pt;">&nbsp;</td>
			<td style="width: 27pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">(vii)</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">an earnings estimate or revision of a previously released earnings estimate;</p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 54pt;">&nbsp;</td>
			<td style="width: 27pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">(viii)</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">major litigation or the threat of major litigation;</p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 54pt;">&nbsp;</td>
			<td style="width: 27pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">(ix)</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">significant management developments such as resignations or new appointments;</p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 54pt;">&nbsp;</td>
			<td style="width: 27pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">(x)</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">a significant increase or decrease in sales or earnings;</p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 54pt;">&nbsp;</td>
			<td style="width: 27pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">(xi)</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">the receipt of FDA or other regulatory approvals; and</p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 54pt;">&nbsp;</td>
			<td style="width: 27pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">(xii)</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">the discovery of a new product or the issuance of an important patent.</p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;"><u>This list is not exhaustive; </u>if in doubt about whether information is material, do not trade in the Company's securities and do not discuss the information outside of the Company unless and until the information becomes public through proper channels. Bear in mind that your conduct will be viewed with the benefit of hindsight.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;"><b><u>What is Non-Public Information?</u></b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 27pt;">An insider may trade only when he or she is certain that official announcements of material information have been sufficiently publicized so that the public has had the opportunity to evaluate it. Thus, insider trading is not made permissible merely because material information is reflected in rumors or other unofficial statements in the press or marketplace. An insider may not attempt to "beat the market" by trading simultaneously with, or shortly after, the official release of such information. As a normal rule, information is considered non-public until at least two full trading days have passed after the information is released by the Company to a national wire service. For example, if an announcement is made on a Monday, trading should not occur until Thursday. The Chief Financial Officer of the Company will know when information has been released to the public.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">&nbsp;</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;"><b><u>What are the Penalties for Insider Trading?</u></b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">The consequences of insider trading violations can be enormous:</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 27pt;">For individuals who trade on inside information or who tip such information to others:</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 54pt;">&nbsp;</td>
			<td style="width: 27pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">&#8226;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">a civil penalty of up to three times the profit gained or the loss avoided</p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 54pt;">&nbsp;</td>
			<td style="width: 27pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">&#8226;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">a criminal fine (no matter how small the profit) of up to $1 million; and</p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 54pt;">&nbsp;</td>
			<td style="width: 27pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">&#8226;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">a jail term of up to ten years.</p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Individuals also may be prohibited from serving as directors or officers of the Company or any other public company.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">These penalties are in addition to any sanctions the Company itself may impose, including dismissal for cause.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; width: 100%;">

		<tr>
			<td style="width: 50%; border-bottom: 1px solid rgb(0, 0, 0); padding-left: 27pt;"><i><u>Eric Lonnqvist</u></i><u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</u></td>
			<td style="width: 50%; border-bottom: 1px solid rgb(0, 0, 0); text-align: center;">&nbsp;Apr 13, 2023</td>
		</tr>
		<tr>
			<td style="padding-left: 27pt;">Name&nbsp;</td>
			<td style="text-align: center;">Date</td>
		</tr>

</table>

<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</p>

<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</p>

<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">&nbsp;</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><b>Whistle-Blower Policy </b></p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><b>iCAD, Inc.</b></p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 27pt;">iCAD, Inc. (the "Company") has established a procedure by which employees, officers, consultants, and contractors can report to the Company allegations of known or suspected Improper Activities (as hereinafter defined).</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 27pt;">"Improper Activities" include, but are not limited to, (i) questionable accounting, internal accounting controls or auditing matters; (ii) disclosures in documents filed by the Company with the Securities and Exchange Commission (the "SEC") and other public disclosures made by the Company that may not be complete or accurate; (iii) violations of the Company's Code of Conduct; (iv) violations of federal or state securities laws or other laws applicable to the Company; (v) wire fraud, mail fraud, bank fraud, or any fraud against the Company's stockholders or under statute; (vi) forgery or alteration of documents; (vii) misappropriation or misuse of Company resources, such as funds or other assets; (viii) authorizing or receiving compensation for goods not received or services not performed; or</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">(ix) any other activity by an employee that is undertaken in the performance of the employee's official duties, whether or not that action is within the scope of his or her employment, and that is in violation of any state or federal law or regulation, or constitutes malfeasance, bribery, fraud, misuse of Company property, or willful omission to perform his or her duties, or involves gross misconduct.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 27pt;">Employees are encouraged to use the guidance provided by this policy for reporting Improper Activities in accordance with the following:</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 27pt;">1.<i>&nbsp;&nbsp;&nbsp;&nbsp;Reporting Requirement. </i>All officers, directors, consultants, and employees are required to report information concerning Improper Activities. Such reports are encouraged to be made in writing to assure a clear understanding of the issues but may be oral. Such reports should be factual rather than speculative or conclusory and should contain specific information to allow for proper assessment of the nature, extent and urgency of the issues raised in the report.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 45pt;">Reporting employees should refrain from (i) obtaining evidence for which they do not have a right of access and (ii) conducting their own investigative activities.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 45pt;">It is the Company's policy that no employee shall be subject to disciplinary or retaliatory action by the Company or any of its employees or agents because of the employee's submitting a report hereunder. However, employees who file reports of Improper Activities or provide evidence which they know to be false or without a reasonable belief in the truth and accuracy ofsuch information will not be protected by the above policy statement and may be subject to disciplinary action and legal claims.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">&nbsp;</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 45pt;">Reporting employees that report Improper Activities on an anonymous basis must provide sufficient corroborating evidence to justify the commencement of an investigation. Unspecified wrongdoing or broad allegations without verifiable evidentiary support may not lead to an investigation. Because of the inability of investigators to interview anonymous reporting employees, it may be more difficult to evaluate the credibility of an Improper Activity and therefore, it may be less likely that an investigation of an anonymous report will be initiated.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 45pt;">2.<i>&nbsp;&nbsp;&nbsp;&nbsp;Procedure for Reporting Improper Activities. </i>To submit a report involving any known or suspected Improper Activity, an employee may contact the Audit Committee of the Company's Board of Directors by calling 603-821-4896 and leaving a voicemail message, sending an e-mail to <u>auditcommittee@icadmed.com</u>, or sending a letter to the Audit Committee in care of the Company's headquarters office in Nashua, New Hampshire. Employees are encouraged to provide as much specific information as possible including names, dates, places and events that took place, and the employee's perception of why the incident(s) constitute an Improper Activity. Anonymous written or telephonic communications will be accepted. Reports submitted through this process that involve the Company's accounting, auditing, and internal auditing controls and disclosure practices will be presented by the Chair of the Audit Committee to the full Audit Committee of the Company's Board of Directors. An employee may utilize this process either to raise new complaints or if he or she feels that a complaint previously raised has not been appropriately handled.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 27pt;">The Audit Committee of the Company's Board of Directors will report to the full Board of Directors of the Company on matters arising under this Policy. The responsibilities of the Chairman of the Audit Committee under this Policy include oversight of the following matters:</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#8226;&nbsp; &nbsp; &nbsp;Administering, implementing, and overseeing ongoing compliance under the Policy.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#8226;&nbsp; &nbsp; &nbsp;Establishing, amending where necessary and administering procedures to assure that reports of Improper Activities will be collected, reviewed promptly, treated, or resolved in an appropriate manner, and retained.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#8226;&nbsp; &nbsp; &nbsp;Establishing, amending where necessary and administering procedures that enable employees to submit reports of Improper Activities and related concerns in a confidential and anonymous manner.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#8226;&nbsp; &nbsp; &nbsp;Ensuring that the individuals at the Company who are responsible for preparing and reviewing the Company's public filings with the SEC and other public disclosures are made aware of reports of improper Activities involving the Company's accounting, auditing, and internal auditing controls, or disclosure practices.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 50pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; width: 100%;">

		<tr>
			<td style="width: 25%; border-bottom: 1px solid rgb(0, 0, 0);"><i><u>Eric Lonnqvist&nbsp; &nbsp; &nbsp; &nbsp;&nbsp;</u></i></td>
			<td style="width: 5%;">&nbsp;</td>
			<td style="width: 20%; border-bottom: 1px solid rgb(0, 0, 0);">Apr 13, 2023</td>
			<td style="width: 50%;">&nbsp;</td>
		</tr>
		<tr>
			<td style="width: 25%; text-align: center;">Name</td>
			<td style="width: 5%;">&nbsp;</td>
			<td style="width: 20%; text-align: center;">Date</td>
			<td style="width: 50%;">&nbsp;</td>
		</tr>

</table>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 50pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">&nbsp;</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 24pt; font-variant: normal; margin: 0pt;">Lonnqvist, Eric Offer Letter</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; width: 100%;">

		<tr>
			<td style="width: 50%;">Final Audit Report</td>
			<td style="width: 50%; text-align: center;">2023-04-13</td>
		</tr>

</table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</p>

<div><img alt="b05.jpg" src="b05.jpg"></div>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 18pt; font-variant: normal; margin: 0pt;">"Lonnqvist, Eric Offer Letter" History</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;"><img alt="b07.jpg" src="b07.jpg"></p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Names and email addresses are entered into the Acrobat Sign service by Acrobat Sign users and are unverified unless otherwise noted.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<div style="margin: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"><img alt="b06.jpg" src="b06.jpg"></div>

<div style="margin: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</div>

<div class="LAST-PAGE-BREAK">
<div class="PGFTR">
<div class="hf-row">
<div class="hf-cell PGNUM">&nbsp;</div>
</div>
</div>
</div>


</body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>3
<FILENAME>ex_501442.htm
<DESCRIPTION>EXHIBIT 99.1
<TEXT>
<html>
	<head>

		<title>
			ex_501442.htm
		</title><!-- Generated by ThunderDome Portal 4/16/2023 6:29:45 PM -->
		<meta charset="utf-8" />
		<meta name="format-detection" content="telephone=no" />

	</head>
	<body style="font-size:10pt;font-family:&#39;Times New Roman&#39;;padding:0in .1in;">
		<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;"><b>Exhibit 99.1</b></p>
		<p style="font-family:&#39;Times New Roman&#39;;font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>
		<p style="font-family:Times New Roman;font-size:12pt;font-variant:normal;text-align:center;margin:0pt;"><b>iCAD Strengthens Leadership Team with Appointment of Chief Financial Officer and New Senior Executives</b></p>
		<p style="font-family:&#39;Times New Roman&#39;;font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>
		<p style="font-family:Times New Roman;font-size:12pt;font-variant:normal;text-align:center;margin:0pt;"><b><i>Eric Lonnqvist as Chief Financial Officer, Vasu Avadhanula as Chief Product Officer, and Michelle Strong as Chief Operations Officer bolster the Company</i></b>&#8217;<b><i>s executive leadership team and accelerate the Company</i></b>&#8217;<b><i>s growth strategies </i></b></p>
		<p style="font-family:&#39;Times New Roman&#39;;font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>
		<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">NASHUA, N.H., April 17, 2023 &#8211; iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today announced the Board of Directors has approved the appointment of Eric Lonnqvist as Chief Financial Officer (CFO), effective immediately, as well as Vasu Avadhanula as Chief Product Officer (CPO) and Michelle Strong as Chief Operations Officer (COO), effective May 1. </p>
		<p style="font-family:&#39;Times New Roman&#39;;font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>
		<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#8220;As we explore new strategic approaches to execute our mission and expand our impact worldwide, experienced and visionary leadership is critical to the success of our organization. Eric, Vasu, and Michelle bring proven expertise to drive growth, increase revenue, and ensure long-term success,&#8221; said Dana Brown, President and Chief Executive Officer of iCAD. &#8220;While we have recently implemented measures to reduce expenses, we remain focused on strategically investing in our Detection business and addressing some of the top issues threatening women&#8217;s health today, such as breast cancer and cardiovascular disease. The addition of these seasoned executives will accelerate key initiatives in the Company&#8217;s strategic expansion, such as new partnerships with patient advocacy groups, pharmaceutical companies, and payer organizations. I am confident that their unique skillsets and contributions will be invaluable to our progress, and we are pleased to welcome them to the team as we work to scale the impact of our AI solutions and revolutionize patient care.&#8221;</p>
		<p style="font-family:&#39;Times New Roman&#39;;font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>
		<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Eric Lonnqvist Appointed as Chief Financial Officer</b></p>
		<p style="font-family:&#39;Times New Roman&#39;;font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>
		<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#8220;On behalf of the Board of Directors, I am pleased to congratulate Eric on his promotion to CFO. Eric has demonstrated strong financial acumen and a commitment to excellence in his position as Vice President of Financial Planning and Analysis at iCAD since 2021, which will continue to be instrumental in leading the financial operations of the Company. We would also like to thank Daniel Shea for his contributions to iCAD during his tenure as interim CFO in recent months, and we wish him the best in his future endeavors,&#8221; Ms. Brown added.</p>
		<p style="font-family:&#39;Times New Roman&#39;;font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>
		<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Mr. Lonnqvist brings more than 15 years of finance and accounting experience in the medical device and technology industries. Prior to joining iCAD, he previously held financial roles at companies including NetBrain Technologies, TripAdvisor, Interactive Data Corporation, and Oracle. Mr. Lonnqvist holds a Bachelor&#8217;s degree from Fitchburg State University and a Master of Business Administration from Assumption University. </p>
		<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"> </p>
		<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&quot;I am honored to accept the position as CFO and pleased to continue to partner with our talented team to build on our momentum and deliver shareholder value. iCAD&#8217;s technologies are revolutionizing the way breast cancer is detected, and I look forward to contributing to the success of the Company in this next phase of growth and innovation,&#8221; said Mr. Lonnqvist. </p>
		<p style="font-family:&#39;Times New Roman&#39;;font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>
		<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Vasu Avadhanula joins as Chief Product Officer</b></p>
		<p style="font-family:&#39;Times New Roman&#39;;font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>
		<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#8220;With a track record of turning new ideas into successful products that disrupt the status quo and enhance the customer experience, Vasu is an outstanding leader with a proven ability to build and scale high performing global teams,&#8221; said Ms. Brown. &#8220;In his last role at Susan G. Komen&#174;, Vasu was instrumental in the success of Komen&#39;s direct-to-patient programs and services, including the development and launch of Komen Health Cloud, a SaaS patient engagement platform as well as Share For Cures, the first patient-powered breast cancer research registry, driving digital transformation and expanding revenue opportunities. I am pleased to welcome him to the team and look forward to incorporating his unique perspective into our future roadmap.&#8221;</p>
		<p style="font-family:&#39;Times New Roman&#39;;font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>
		<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Mr. Avadhanula brings more than 25 years of product development, business analytics, and technology innovation experience in the healthcare and technology industries. Prior to joining iCAD, he previously served as VP, Health Technology and Digital Transformation at Susan G. Komen, as well as a range of senior executive roles at SigmaFlow, Ignite Technologies, Thomson Reuters, and Abbott Laboratories. Mr. Avadhanula holds a Bachelor of Engineering from University of Madras, as well as certifications from Johns Hopkins University and the Wharton School of the University of Pennsylvania. In his role as CPO, he will oversee the Company&#8217;s overall product strategy and roadmap.</p>
		<p style="font-family:&#39;Times New Roman&#39;;font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>
		<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#8220;With a legacy of leadership in breast AI, iCAD&#8217;s innovation track record has transformed the landscape of breast cancer screening and presents tremendous potential for the future. I am delighted to join the iCAD team and look forward to building on the Company&#8217;s culture of continuous improvement to accelerate the Company&#8217;s growth and enhance the customer experience on a global scale,&#8221; said Mr. Avadhanula.</p>
		<p style="font-family:&#39;Times New Roman&#39;;font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>
		<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Michelle Strong joins as Chief Operations Officer</b></p>
		<p style="font-family:&#39;Times New Roman&#39;;font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>
		<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#8220;A seasoned commercial leader, Michelle excels at strategically building and growing organizations, tackling challenging initiatives, and developing strategic partnerships. She specializes in the implementation of new business strategies that broaden awareness, bolster brand equity and drive revenue growth,&#8221; said Ms. Brown. &#8220;In her last role at Susan G. Komen, she set the overarching marketing and business development strategy for the organization. Under Michelle&#8217;s leadership, Komen&#8217;s brand health experienced significant improvement year-over-year, resulting in increased revenues and stakeholder engagement to advance its mission to save lives from breast cancer. I am pleased to welcome her to the team and am confident that her unique set of skills and expertise will be instrumental to our go-to-market success.&#8221;</p>
		<p style="font-family:&#39;Times New Roman&#39;;font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>
		<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Ms. Strong joins the Company with more than 25 years of experience in marketing and healthcare technology, most recently serving as VP of Marketing Strategy at Susan G. Komen. Prior to that role, she held senior executive roles at LRS, Dealtaker, and Belo Interactive. She holds a Bachelor of Science from Bradley University and completed a marketing graduate program at Southern Methodist University. In her position as COO, Michelle will lead the Company&#8217;s sales, marketing and partner success teams, as well as launch new revenue-generating partnership initiatives to accelerate growth, increase revenue, and achieve profitability. </p>
		<p style="font-family:&#39;Times New Roman&#39;;font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>
		<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#8220;As the global leader in breast AI, iCAD&#8217;s market position and track record of innovation have solidified its brand equity and present promising potential for growth,&#8221; said Ms. Strong. &#8220;With breast cancer being the most common cancer among women worldwide, the need has never been greater for iCAD&#8217;s robust suite of solutions and I look forward to working with the team to harness the large, addressable market opportunity and expand our impact around the world.&#8221;</p>
		<p style="font-family:&#39;Times New Roman&#39;;font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>
		<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>About iCAD, Inc.</b></p>
		<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Headquartered in Nashua, NH, iCAD&#174; is a global medical technology leader providing innovative cancer detection and therapy solutions. For more information, visit www.icadmed.com.</p>
		<p style="font-family:&#39;Times New Roman&#39;;font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>
		<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Forward-Looking Statements                                    </b></p>
		<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Certain statements contained in this News Release constitute &#8220;forward-looking statements&#8221; within the meaning of the Private Securities Litigation Reform Act of 1995, including statements about the expansion of access to the Company&#8217;s products, improvement of performance, acceleration of adoption, expected benefits of ProFound AI&#174;, the benefits of the Company&#8217;s products, and future prospects for the Company&#8217;s technology platforms and products. Such forward-looking statements involve a number of known and unknown risks, uncertainties and other factors which may cause the actual results, performance, or achievements of the Company to be materially different from any future results, performance, or achievements expressed or implied by such forward-looking statements. Such factors include, but are not limited, to the Company&#8217;s ability to achieve business and strategic objectives, the willingness of patients to undergo mammography screening in light of risks of potential exposure to Covid-19, whether mammography screening will be treated as an essential procedure, whether ProFound AI will improve reading efficiency, improve specificity and sensitivity, reduce false positives and otherwise prove to be more beneficial for patients and clinicians, the impact of supply and manufacturing constraints or difficulties on our ability to fulfill our orders, uncertainty of future sales levels, to defend itself in litigation matters, protection of patents and other proprietary rights, product market acceptance, possible technological obsolescence of products, increased competition, government regulation, changes in Medicare or other reimbursement policies, risks relating to our existing and future debt obligations, competitive factors, the effects of a decline in the economy or markets served by the Company; and other risks detailed in the Company&#8217;s filings with the Securities and Exchange Commission. The words &#8220;believe,&#8221; &#8220;demonstrate,&#8221; &#8220;intend,&#8221; &#8220;expect,&#8221; &#8220;estimate,&#8221; &#8220;will,&#8221; &#8220;continue,&#8221; &#8220;anticipate,&#8221; &#8220;likely,&#8221; &#8220;seek,&#8221; and similar expressions identify forward-looking statements. Readers are cautioned not to place undue reliance on those forward-looking statements, which speak only as of the date the statement was made. The Company is under no obligation to provide any updates to any information contained in this release. For additional disclosure regarding these and other risks faced by iCAD, please see the disclosure contained in our public filings with the Securities and Exchange Commission, available on the Investors section of our website at http://www.icadmed.com and on the SEC&#8217;s website at http://www.sec.gov.</p>
		<p style="font-family:&#39;Times New Roman&#39;;font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>
		<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"> </p>
		<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Contact:</p>
		<p style="font-family:&#39;Times New Roman&#39;;font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>
		<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Media Inquiries:</p>
		<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Jessica Burns, iCAD </p>
		<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">+1-201-423-4492</p>
		<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">jburns@icadmed.com</p>
		<p style="font-family:&#39;Times New Roman&#39;;font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>
		<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Investor Inquiries:</p>
		<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">iCAD Investor Relations</p>
		<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">ir@icadmed.com</p>
		<p style="font-family:&#39;Times New Roman&#39;;font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

	</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>4
<FILENAME>icad-20230413.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
<!--Generated by ThunderDome Portal - 4/17/2023 6:25:42 PM-->
<xsd:schema xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xsd="http://www.w3.org/2001/XMLSchema" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:stpr="http://xbrl.sec.gov/stpr/2021" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:num="http://www.xbrl.org/dtr/type/numeric" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:dei="http://xbrl.sec.gov/dei/2021q4" xmlns:country="http://xbrl.sec.gov/country/2021" xmlns:sic="http://xbrl.sec.gov/sic/2021" xmlns:currency="http://xbrl.sec.gov/currency/2021" xmlns:exch="http://xbrl.sec.gov/exch/2021" xmlns:icad="http://www.icad.com/20230413" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.icad.com/20230413">
<xsd:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
<xsd:import namespace="http://www.xbrl.org/2009/role/negated" schemaLocation="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd"/>
<xsd:import namespace="http://www.xbrl.org/dtr/type/non-numeric" schemaLocation="http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd"/>
<xsd:import namespace="http://xbrl.sec.gov/stpr/2021" schemaLocation="https://xbrl.sec.gov/stpr/2021/stpr-2021.xsd"/>
<xsd:import namespace="http://www.xbrl.org/dtr/type/numeric" schemaLocation="http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd"/>
<xsd:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd"/>
<xsd:import namespace="http://xbrl.sec.gov/dei/2021q4" schemaLocation="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd"/>
<xsd:import namespace="http://xbrl.sec.gov/country/2021" schemaLocation="https://xbrl.sec.gov/country/2021/country-2021.xsd"/>
<xsd:import namespace="http://xbrl.sec.gov/sic/2021" schemaLocation="https://xbrl.sec.gov/sic/2021/sic-2021.xsd"/>
<xsd:import namespace="http://xbrl.sec.gov/currency/2021" schemaLocation="https://xbrl.sec.gov/currency/2021/currency-2021.xsd"/>
<xsd:import namespace="http://xbrl.sec.gov/exch/2021" schemaLocation="https://xbrl.sec.gov/exch/2021/exch-2021.xsd"/>

<xsd:annotation>
<xsd:appinfo>
<link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="icad-20230413_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
<link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="icad-20230413_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"/>
<link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="icad-20230413_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
<link:roleType id="statement-document-and-entity-information" roleURI="http://www.icad.com/20230413/role/statement-document-and-entity-information">
<link:definition xmlns="http://www.xbrl.org/2003/linkbase">000 - Document - Document And Entity Information</link:definition>
<link:usedOn>link:calculationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:presentationLink</link:usedOn>
</link:roleType>
</xsd:appinfo>
</xsd:annotation>
<xsd:element abstract="true" id="icad_DocumentAndEntityInformation" name="DocumentAndEntityInformation" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration"/>
</xsd:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>5
<FILENAME>icad-20230413_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
<!--Generated by ThunderDome Portal - 4/17/2023 6:25:42 PM-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
<link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" xlink:type="simple"/>
<link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" xlink:type="simple"/>
<link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" xlink:type="simple"/>
<link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" xlink:type="simple"/>
<link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" xlink:type="simple"/>
<link:roleRef roleURI="http://www.icad.com/20230413/role/statement-document-and-entity-information" xlink:href="icad-20230413.xsd#statement-document-and-entity-information" xlink:type="simple"/>
<link:definitionLink xlink:role="http://www.icad.com/20230413/role/statement-document-and-entity-information" xlink:type="extended">
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain-default" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentInformationTable" xlink:label="dei_DocumentInformationTable" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentInformationLineItems" xlink:label="dei_DocumentInformationLineItems" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentType" xlink:label="dei_DocumentType" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" xlink:type="locator"/>
<link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" xlink:type="arc"/>
<link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain-default" xlink:type="arc"/>

<link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="dei_DocumentInformationTable" xlink:to="dei_LegalEntityAxis" xlink:type="arc"/>


<link:definitionArc order="0" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentInformationTable" xlink:type="arc"/>
<link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentType" xlink:type="arc"/>
<link:definitionArc order="2" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentPeriodEndDate" xlink:type="arc"/>
<link:definitionArc order="3" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityRegistrantName" xlink:type="arc"/>
<link:definitionArc order="4" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityIncorporationStateCountryCode" xlink:type="arc"/>
<link:definitionArc order="5" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityFileNumber" xlink:type="arc"/>
<link:definitionArc order="6" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityTaxIdentificationNumber" xlink:type="arc"/>
<link:definitionArc order="7" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressAddressLine1" xlink:type="arc"/>
<link:definitionArc order="8" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressCityOrTown" xlink:type="arc"/>
<link:definitionArc order="9" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressStateOrProvince" xlink:type="arc"/>
<link:definitionArc order="10" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressPostalZipCode" xlink:type="arc"/>
<link:definitionArc order="11" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_CityAreaCode" xlink:type="arc"/>
<link:definitionArc order="12" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_LocalPhoneNumber" xlink:type="arc"/>
<link:definitionArc order="13" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_WrittenCommunications" xlink:type="arc"/>
<link:definitionArc order="14" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_SolicitingMaterial" xlink:type="arc"/>
<link:definitionArc order="15" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_PreCommencementTenderOffer" xlink:type="arc"/>
<link:definitionArc order="16" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_PreCommencementIssuerTenderOffer" xlink:type="arc"/>
<link:definitionArc order="17" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_Security12bTitle" xlink:type="arc"/>
<link:definitionArc order="18" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_TradingSymbol" xlink:type="arc"/>
<link:definitionArc order="19" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_SecurityExchangeName" xlink:type="arc"/>
<link:definitionArc order="20" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityEmergingGrowthCompany" xlink:type="arc"/>
<link:definitionArc order="21" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_AmendmentFlag" xlink:type="arc"/>
<link:definitionArc order="22" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityCentralIndexKey" xlink:type="arc"/>

</link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>6
<FILENAME>icad-20230413_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
<!--Generated by ThunderDome Portal - 4/17/2023 6:25:42 PM-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
<link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" xlink:type="simple"/>
<link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" xlink:type="simple"/>
<link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" xlink:type="simple"/>
<link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" xlink:type="simple"/>
<link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" xlink:type="simple"/>
<link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" xlink:type="simple"/>
<link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" xlink:type="simple"/>
<link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain" xlink:type="locator"/>
<link:label xlink:label="dei_EntityDomain-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity [Domain]</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityDomain" xlink:to="dei_EntityDomain-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis" xlink:type="locator"/>
<link:label xlink:label="dei_LegalEntityAxis-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Legal Entity [Axis]</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LegalEntityAxis" xlink:to="dei_LegalEntityAxis-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentInformationLineItems" xlink:label="dei_DocumentInformationLineItems" xlink:type="locator"/>
<link:label xlink:label="dei_DocumentInformationLineItems-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Information [Line Items]</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentInformationLineItems-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentInformationTable" xlink:label="dei_DocumentInformationTable" xlink:type="locator"/>
<link:label xlink:label="dei_DocumentInformationTable-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Information [Table]</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentInformationTable" xlink:to="dei_DocumentInformationTable-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentType" xlink:label="dei_DocumentType" xlink:type="locator"/>
<link:label xlink:label="dei_DocumentType-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document, Type</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" xlink:type="locator"/>
<link:label xlink:label="dei_DocumentPeriodEndDate-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document, Period End Date</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" xlink:type="locator"/>
<link:label xlink:label="dei_EntityRegistrantName-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity, Registrant Name</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" xlink:type="locator"/>
<link:label xlink:label="dei_EntityIncorporationStateCountryCode-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity, Incorporation, State or Country Code</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" xlink:type="locator"/>
<link:label xlink:label="dei_EntityFileNumber-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity, File Number</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" xlink:type="locator"/>
<link:label xlink:label="dei_EntityTaxIdentificationNumber-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity, Tax Identification Number</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" xlink:type="locator"/>
<link:label xlink:label="dei_EntityAddressAddressLine1-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity, Address, Address Line One</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" xlink:type="locator"/>
<link:label xlink:label="dei_EntityAddressCityOrTown-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity, Address, City or Town</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" xlink:type="locator"/>
<link:label xlink:label="dei_EntityAddressStateOrProvince-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity, Address, State or Province</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" xlink:type="locator"/>
<link:label xlink:label="dei_EntityAddressPostalZipCode-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity, Address, Postal Zip Code</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" xlink:type="locator"/>
<link:label xlink:label="dei_CityAreaCode-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">City Area Code</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" xlink:type="locator"/>
<link:label xlink:label="dei_LocalPhoneNumber-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Local Phone Number</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" xlink:type="locator"/>
<link:label xlink:label="dei_WrittenCommunications-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Written Communications</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" xlink:type="locator"/>
<link:label xlink:label="dei_SolicitingMaterial-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Soliciting Material</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" xlink:type="locator"/>
<link:label xlink:label="dei_PreCommencementTenderOffer-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" xlink:type="locator"/>
<link:label xlink:label="dei_PreCommencementIssuerTenderOffer-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" xlink:type="locator"/>
<link:label xlink:label="dei_Security12bTitle-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Title of 12(b) Security</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" xlink:type="locator"/>
<link:label xlink:label="dei_TradingSymbol-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Symbol</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" xlink:type="locator"/>
<link:label xlink:label="dei_SecurityExchangeName-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Security Exchange Name</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" xlink:type="locator"/>
<link:label xlink:label="dei_EntityEmergingGrowthCompany-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity, Emerging Growth Company</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" xlink:type="locator"/>
<link:label xlink:label="dei_AmendmentFlag-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Amendment Flag</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" xlink:type="locator"/>
<link:label xlink:label="dei_EntityCentralIndexKey-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity, Central Index Key</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey-label" xlink:type="arc"/>

</link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>7
<FILENAME>icad-20230413_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
<!--Generated by ThunderDome Portal - 4/17/2023 6:25:42 PM-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
<link:roleRef roleURI="http://www.icad.com/20230413/role/statement-document-and-entity-information" xlink:href="icad-20230413.xsd#statement-document-and-entity-information" xlink:type="simple"/>
<link:presentationLink xlink:role="http://www.icad.com/20230413/role/statement-document-and-entity-information" xlink:type="extended">
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentInformationTable" xlink:label="dei_DocumentInformationTable" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentInformationLineItems" xlink:label="dei_DocumentInformationLineItems" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentType" xlink:label="dei_DocumentType" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" xlink:type="locator"/>
<link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" xlink:type="arc"/>

<link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationTable" xlink:to="dei_LegalEntityAxis" xlink:type="arc"/>

<link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationTable" xlink:to="dei_DocumentInformationLineItems" xlink:type="arc"/>
<link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityRegistrantName" xlink:type="arc"/>
<link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentType" xlink:type="arc"/>
<link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentPeriodEndDate" xlink:type="arc"/>
<link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityIncorporationStateCountryCode" xlink:type="arc"/>
<link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityFileNumber" xlink:type="arc"/>
<link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityTaxIdentificationNumber" xlink:type="arc"/>
<link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressAddressLine1" xlink:type="arc"/>
<link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressCityOrTown" xlink:type="arc"/>
<link:presentationArc order="8" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressStateOrProvince" xlink:type="arc"/>
<link:presentationArc order="9" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressPostalZipCode" xlink:type="arc"/>
<link:presentationArc order="10" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_CityAreaCode" xlink:type="arc"/>
<link:presentationArc order="11" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_LocalPhoneNumber" xlink:type="arc"/>
<link:presentationArc order="12" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_WrittenCommunications" xlink:type="arc"/>
<link:presentationArc order="13" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_SolicitingMaterial" xlink:type="arc"/>
<link:presentationArc order="14" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_PreCommencementTenderOffer" xlink:type="arc"/>
<link:presentationArc order="15" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_PreCommencementIssuerTenderOffer" xlink:type="arc"/>
<link:presentationArc order="16" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_Security12bTitle" xlink:type="arc"/>
<link:presentationArc order="17" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_TradingSymbol" xlink:type="arc"/>
<link:presentationArc order="18" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_SecurityExchangeName" xlink:type="arc"/>
<link:presentationArc order="19" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityEmergingGrowthCompany" xlink:type="arc"/>
<link:presentationArc order="20" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_AmendmentFlag" xlink:type="arc"/>
<link:presentationArc order="21" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityCentralIndexKey" xlink:type="arc"/>

</link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>8
<FILENAME>b01.jpg
<TEXT>
begin 644 b01.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_X0!P17AI9@  34T *@    @ !@$Q  (
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M"?4KV4#/EP0QM)(V/95)KSK]AWQ!J7Q"_9J\-^-M<&W6OB%;KXGNX\Y^RBZ
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MM%'W91117RIZ1E^-_#S>+O!>L:2LBQ-JEE-:!V&X)YD;)DCOC->7_P#!/_\
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M6HHE@B6.-51$ 5548"@= !3JX<9C95VE;EC':*V7^;[OJ:4J*AKNWNS\Z?\
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#&?_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>9
<FILENAME>b02.jpg
<TEXT>
begin 644 b02.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_X0!P17AI9@  34T *@    @ !@$Q  (
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M1_,=\:?C1XL_::^+NK^,/%^J7GB'Q3XDNO.N;F7YGE<\*B*.%51A510 H
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3]R?9H!TYZ]Z***YS0**** /_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>10
<FILENAME>b03.jpg
<TEXT>
begin 644 b03.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_X0!P17AI9@  34T *@    @ !@$Q  (
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MKX->&[6;4M:^(B&1(X+_ %> HLLEK)<21+#;2+! 6DA^T<E4;[U_X89^%2_
M3Q%\,X_"-O;^$/%]L;77(8+RYAO=74J$+W%ZD@NY9=H"^:TIDP -V!5#7_\
M@GK\(?$W@.W\.W?A.3['#KEEXF:[AUB^@U6ZU.S8-;7D]_',MW<31D##2RN2
M!@Y'% 'P3JW[2/[0W[;/Q1LO"K0ZS\-]2U*S%SH_PA\*ZQ)IE]H.G.SI%JGC
M'7K9?/TM,(3'I]@T=U(P$><K(R?I'^SW\*_$'PB^"/A?PSXD\>:[X\U[0]/B
MM+[Q!J,,$=SJDJCF1E1/P&XLY !=Y'+.Q\)_V:?!/P-\9>+->\*:.VCZAXVD
DLY=76.^N)+69K6W6VA,=N\AAMR(E4-Y*)YA 9]S?-7=T ?_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>11
<FILENAME>b04.jpg
<TEXT>
begin 644 b04.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_X0!P17AI9@  34T *@    @ !@$Q  (
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M>>5MJ!Y&Y)X!9N/2NBDO88;-KAYHUMU3S&E+ (%QG<3TQCG-?B[\3/VOY?\
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%** /_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>12
<FILENAME>b05.jpg
<TEXT>
begin 644 b05.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_X0!P17AI9@  34T *@    @ !@$Q  (
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MII^C>$-9\03/:1RK$\S#3[6?8HD95R^WEAZUPW_#Y3X$_P#/S\6O_#.^,?\
MY5USWQ,_Y3;^%O\ LA^J_P#I^TZOHJ@#Q;_A\I\"?^?GXM?^&=\8_P#RKH_X
M?*? G_GY^+7_ (9WQC_\JZ]IHH \6_X?*? G_GY^+7_AG?&/_P JZ/\ A\I\
M"?\ GY^+7_AG?&/_ ,JZ]IHH \6_X?*? G_GY^+7_AG?&/\ \JZ/^'RGP)_Y
M^?BU_P"&=\8__*NO::* /%O^'RGP)_Y^?BU_X9WQC_\ *NC_ (?*? G_ )^?
MBU_X9WQC_P#*NO::* /%O^'RGP)_Y^?BU_X9WQC_ /*NC_A\I\"?^?GXM?\
MAG?&/_RKKVFB@#Q;_A\I\"?^?GXM?^&=\8__ "KH_P"'RGP)_P"?GXM?^&=\
M8_\ RKKVFB@#Q;_A\I\"?^?GXM?^&=\8_P#RKH_X?*? G_GY^+7_ (9WQC_\
MJZ]IHH \6_X?*? G_GY^+7_AG?&/_P JZ/\ A\I\"?\ GY^+7_AG?&/_ ,JZ
M]IHH \6_X?*? G_GY^+7_AG?&/\ \JZ/^'RGP)_Y^?BU_P"&=\8__*NO::*
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MBU_X9WQC_P#*NO::* /%O^'RGP)_Y^?BU_X9WQC_ /*NC_A\I\"?^?GXM?\
MAG?&/_RKKVFB@#Q;_A\I\"?^?GXM?^&=\8__ "KH_P"'RGP)_P"?GXM?^&=\
M8_\ RKKVFB@#Q;_A\I\"?^?GXM?^&=\8_P#RKH_X?*? G_GY^+7_ (9WQC_\
MJZ]IHH \6_X?*? G_GY^+7_AG?&/_P JZ/\ A\I\"?\ GY^+7_AG?&/_ ,JZ
M]IHH \6_X?*? G_GY^+7_AG?&/\ \JZ/^'RGP)_Y^?BU_P"&=\8__*NO::*
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MBU_X9WQC_P#*NO::* /%O^'RGP)_Y^?BU_X9WQC_ /*NC_A\I\"?^?GXM?\
MAG?&/_RKKVFB@#Q;_A\I\"?^?GXM?^&=\8__ "KH_P"'RGP)_P"?GXM?^&=\
M8_\ RKKVFB@#Q;_A\I\"?^?GXM?^&=\8_P#RKKW/]G_X_>$_VHOA%H_COP/J
M4VK^%]>$ILKJ:QN+&23RIGAD#0W$<<T;+)&ZD.BG*],8JK7C?_!&W_E'AX._
M["OB'_T_:A0!S/Q,_P"4V_A;_LA^J_\ I^TZOHJOG7XF?\IM_"W_ &0_5?\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M_%+XK6^CZAX]TNQT6_N]3M+;P#)>#RW6T.GM*DUDB>;#!Y?R89&(=3SNF_\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M)OK:XC\-:JUG:0ZI<FUL'O+@6WE6/G7"M"!=/$5D!1@K<5L>#O\ @HG\)?B
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M#>:#\.8--;Q)K^@WUKHGQ!.L>*_#D&E-J*OJ>IZ.+"+[)92?V?Q)]H<@WMH
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MMZ'XR\:+HNG^$[B6&2YCEO-16TF"JUL+:4#R>ET@SQDGC'_@C7X<M+?1M)\
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MD3F*94D3<C*=KJK#/(!K<JMHVCVOA[2+73[&WBM;&QA2WMX(EVI#&BA551V
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M_"=T7_Y:T?\ #RSQ9_T:!^UQ_P"$[HO_ ,M: /JFBOE;_AY9XL_Z- _:X_\
M"=T7_P"6M'_#RSQ9_P!&@?M<?^$[HO\ \M: /JFBOE;_ (>6>+/^C0/VN/\
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M&@?M<?\ A.Z+_P#+6@#ZIHKY6_X>6>+/^C0/VN/_  G=%_\ EK1_P\L\6?\
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M: /JFBOE;_AY9XL_Z- _:X_\)W1?_EK1_P /+/%G_1H'[7'_ (3NB_\ RUH
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M_P M: /JFBOE;_AY9XL_Z- _:X_\)W1?_EK1_P /+/%G_1H'[7'_ (3NB_\
MRUH ^J:\;_X(V_\ */#P=_V%?$/_ *?M0KSK_AY9XL_Z- _:X_\ "=T7_P"6
MM>K_ /!)?P-XB^'7[ G@G3/%7A[5O"FO&YU>\N-)U.-8[RQ6XU:\N(TE5690
MWERH2 Q'/4T ?1U%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
)%% !1110!__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>13
<FILENAME>b06.jpg
<TEXT>
begin 644 b06.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_X0!P17AI9@  34T *@    @ !@$Q  (
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M^*+/]K3PC!I_Q$TK5]4EAF\/ZNUH\5S/:S *)(Q+/<O&3G*S -'E QVO!_\
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MVZH;9W,NYB68 8+5Y/\ L3:-KGPF\6>*?V6]!\%_ 7QUXZ_:<^&6L>'U\?\
M@;Q_=>)KNR*:9((7U&6229;>U:14RB)$.00&V*M?T:>-_ FB?$SPI>Z#XDT?
M2]?T34H_*N]/U&U2ZM;E,YVO&X*L,@'!'45P_P  /V+/A#^RE<7TWPS^&/@7
MP'/J0VW<VA:);V,MPN0=KO&H9ER <$XR* /SOLO^"-7QC@^$W_!.[16;PG]L
M_9A\1KJGC/\ XF3;#"+JWE_T4^7^];;$W!V\XK]7J** "BBB@ HHHH ****
G"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** /__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>14
<FILENAME>b07.jpg
<TEXT>
begin 644 b07.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_X0!P17AI9@  34T *@    @ !@$Q  (
M   *    5@,!  4    !    8 ,#  $    !     %$0  $    ! 0   %$1
M  0    !   .PU$2  0    !   .PP    !'<F5E;G-H;W0   &&H   L8__
MVP!#  (! 0(! 0(" @(" @(" P4# P,# P8$! ,%!P8'!P<&!P<("0L)" @*
M" <'"@T*"@L,# P,!PD.#PT,#@L,# S_VP!# 0(" @,# P8# P8," <(# P,
M# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,
M# S_P  1" &Y ?P# 2(  A$! Q$!_\0 'P   04! 0$! 0$           $"
M P0%!@<("0H+_\0 M1   @$# P($ P4%! 0   %] 0(#  01!1(A,4$&$U%A
M!R)Q%#*!D:$((T*QP152T? D,V)R@@D*%A<8&1HE)B<H*2HT-38W.#DZ0T1%
M1D=(24I35%565UA96F-D969G:&EJ<W1U=G=X>7J#A(6&AXB)BI*3E)66EYB9
MFJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&Q\C)RM+3U-76U]C9VN'BX^3EYN?H
MZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$! 0$! 0        $" P0%!@<("0H+
M_\0 M1$  @$"! 0#! <%! 0  0)W  $" Q$$!2$Q!A)!40=A<1,B,H$(%$*1
MH;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF)R@I*C4V-S@Y.D-$149'2$E*4U15
M5E=865IC9&5F9VAI:G-T=79W>'EZ@H.$A8:'B(F*DI.4E9:7F)F:HJ.DI::G
MJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4U=;7V-G:XN/DY>;GZ.GJ\O/T]?;W
M^/GZ_]H # ,!  (1 Q$ /P#]U/C'\7-(^"/@&]U_6KB.&WMT80HQ(-S-M9DB
M7 /+;2,]!UKQ'PQ^V]XE\1V.@ZA8^%_#WB2QUNZ:U-MHFK3R7]NZ6S7,B&.:
MWC5I%B5CM5B&8;0><UZM^T[\/]!^(/P8UF/Q'82:EI^D6\FJBW2X: R/#$[
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M;-YL=JMZ;J)K.WQ+]I",D85XW8O(P!]J?&S]M?X-?LT^)+71OB-\6_AC\/\
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M'PO\3?$SPQ9W=AI^F0)XRATR" HTHCM747$WS6DQMQ&I>T<Q1PMN%9O[-O\
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MJU/Q=XIU#2_A)X?/B?4M(T>:]MK/4_%5_!-!+#;6T5JV8;EV5EAC<1S1_,6
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MJRT/Q!>VUNNC^*)]&N8[358K-XYWF#6UQ)Y9-Q#")#'*83*L;L #TKQ%\ O
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MQ2WCKP[IOAWP_P")'\*V.HWVM6$-KXJOA86U^BZ7+YY2Z\V&ZC$84AG96PN
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MH_B;POX=^&^M>/I/B?%K,$UQ+XELM5;PX-'%FEL8A;^2LX%V+C[0'P!#Y/\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M76E^#[M5O].U/2(+.Y\0:G=Z?H=GJ3!KZWTRTFN'@TN*8A0R6*0#:B* %50
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M@_#'QBNOA:[_  9F\70_&31_AFFNKH.H_P!G&ROO"5QKC7QLO[0\T3K)'&!
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MVHR7;0(N%(+.6^EJ* /F_P 4?\$N_AWXR\+Q:/J-_P"*KC3X_A%=_!=H_M4
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M#/1M,UB?XH_#^QGMM!MYKJ6YCFTR:/[;J&ZXMU@AG=XIR%CO8=\<>59_5_\
M@H[^SKXN_::_9]TO1? W_"-OXDT/QCX=\56\.NZA-86-VNF:M:W[PO/#!</&
M9%@*!A"^"P)&*\ _:7_X)X?&3]LS3_C/X@\26_PM\!^+/'?PZMOA]H^E:-X@
MOM7L)Q'?M>F\O[V33[60E2QCBB2V?RP\QWMYNU #U[PW_P %&_#=Y\3?'6H:
MKK^G:-\-_"O@?2_%*VFJ>%=>TCQ7;/<7^I6C//:7=K&7CG:SCCM8(8VN99-V
M$99K<ON3_P#!4#X*V/PSU#Q9>>)-=TW3]+\1P^$;NRO_  CK-GK-OJ\\"3V]
MDVF2VBWWG31R1F)?(_>F5 FYF4'SG]K+]A;XK?$[XU?&3QG\/?%VD^&+WQWX
M'\*^&M)F36+W2[X2:9K5[>WT,ES;Q-):1W-I=&W6Y@+S1&5W" HN[S3X4_\
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MCX=^//B!Y<D.G?%SQUJGBW2%=]WFZ:PALK*Y7DC9<VUE#=)@_<NESAL@?0U
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M!I8GF4R+&\J3V(DDDCMF7A'D90#[ HK\Y?@]^V%XX\,#0_@OX!NM2\'>.?\
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M\-/A_P#$3^P_-_LW_A)_#UIJ_P#9_F[/-\G[1&_E[_*CW;<;O+3.=HQI:G\
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MXN_:*^.'@G]JGP;H*0_"GQ/H/Q$FU:73?"EA#?6NO:)I=I922P:O>:BTKPM
M]R+2VF1;%!#+JD")+<%-TM_XQ_\ !,+1OVA-"TNU\;?%#XJZ]>1Z3>>&]?U
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MT+X@7'Q_\=?\)-KQ\.S1ZDGA^Y?Q.UO]KEV"1=.D9K)T#L(6>2)U^:0,?/\
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MPZE%''<*]E?7%E*2L;NNTRV[E<,25*DA22H] KX-_P""?7@OQUX#_P""/_\
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M=AIGV'P[I_VZ\3[5=Q6WVAH]RX@A\WS9GS\D4<CX.W!^0_\ @G=^SY!\+?\
M@D#XJ^'*>!?&W@_6(5\5:7J^F^&-('AS7KJXDN;M$GTV6Z6"&2=K9K?[/=[S
M"2D0$F(R%^6? O[/_BS2OV</$GA'P;\*6E\/KXI^&&IMK7A_X1ZY\-WU6\M?
M$EM]O\[P]>/(AF@M8([BXU&T2.%UD"MD6X\L _8ZJFOZM_8.A7M]]FN[S['
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M6_[./BSP[\:YK_PU>V<OCWQ=-9VR6G[Z2(+K]\UXFK2I?6K3#R[DCS<7,<;
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M/-OCMG:00$HK 'U%17AO["?[;5M^W+X7\=ZU8^&-3\,Z=X3\6S^'+'^T)/\
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M;73=4\(2PVMY;VCL]J$=28S$61#M^1UVE1@IW!%>5_\ !8K_ )-I\#?]E>\
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MVXL2<DF@#\O_ -J3XN?%[Q?^P[\2?"WBWXM>)O&%O\3OV4=1^*=T7T31K/\
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M"/BCP=KU]KFNW6G^'+>._P#&+7&CWVF(EU=H4D)B^VF0-()?N%0%W;AZO>_
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M?6%Q9>,6TS3WM/LMG]L>=)%O)(;Z P\^9I\ETL9#"7RO+DV7(O\ @H+\!9_
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M:W9U&."XG410W$MFD,K20LKF.:*1^?\ V&OV$O%O[/GQ;\1^+O&>H>&=3O\
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MC  K]VVGP!UBW_;WU#XI-<Z9_P (_=^ +7PJEN)'^V"ZBU&XNF<KLV>44E4
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MD:/J6DR7'AS5+ZRNOB5YTML+!M81K,BW6RMX&$:F2_8/._EO"C.K^8?M0_\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 V:=+:%I)&6..-2S,QPJ@=23Z5Y,W[=WPC7Q1_8_P#PG&D_:]_E[\2?
M9]V<8\[;Y?X[L>]<5_P55\6:KX4_9'U#^RY)H5U*^@LKQXSAA P=B,^C,J*?
M4,1WKX13]F?2?A+X(F\;>.-8L=8\/ZC8@^&8-&O?WOB"[D3/7&Z*.W;_ %I8
M [@%&<UV4,/&<>:3/RWC'CC,,MQ_U++Z,9*,5.<IMV2=^S32TWUNVHI-M)_K
MY!/'=0)+$ZR1R*&1U.Y6!Y!![@TZOFO_ ()1^*M6\3_LEV:ZI)+,NF:A-9V4
MDAR3 %1@H/HK.ZCT  [5U7_!0_\ :&OOV8?V._&GBC18[JX\4R6R:1X;M[6Q
MGO[BXU:]D2TL@EM CS3[9YD=HXD9RB/@'%<U2'))Q['WV1YI',<OHX^,>55(
MJ5GTNMO/UZGM5%?F+^RS^V7X=_X)X_LO_M >!_"ND^-M4TSX+Z/%XS\$67C/
MP[JOA6ZU2ROT"2QNNIP0SLB:PEV\DZH46.]C5=S(PKK/C]_P4._:"_99\0_$
M[PIX@_X4UXF\1>#M'\!:EI>HZ=H>HZ?97;^(/%$FCW*SV[W\TD8BB0^6%E)+
M*)6RK^2D'J'Z'45^=O[0O_!3_P",_P %?C;XT\$Z/X?M?'NL?!_3-(N=:L?#
MOPD\4:M)X^N[M#<RVUE/8S7%MH>+;8L;7LET7E=B0D:;FO?%C_@J]\2;#]JO
MQYX?\$^!]4U[P[\,O$6C>&KWP]:?#3Q)K>J^(GN8;2YO;I-9L@=,TS[/!?1L
MMO<I*\AM9"SPK/&4 /T$HK\\_$7_  4-_:"O_B)&N@K\&[;P_JGQSU'X*6-I
M?Z)J4UY;+';WDT6M2W"7J)(8O)0-8K"GG^6Q%W;>:/)JZW_P5G^)6D>%O"?A
M6XL_#L?Q"U;XB^,/!6H^(=)\ :]XGTV.VT">13=P:#IT\E^SSJULOEFZ*0EI
MG:5@JHP!^BU%? /@_P#X*#?M ?&_Q7\*?">B^'O"/PQ\2>+/!/BGQ#KC^-O!
MFL,ZSZ+J=E8QS6^GR75E<Q6UXEP9TCN")(TFC)9RA$E?]B+]K+XF?M<?MP_!
MWQA=>(-/T;P5X^_9[MO&-_X0AM;J2"&]FO85=XW-WY7F"5_EE: L(0T9R6\Q
M0#]!J*^8=$_:'^+WQP_:G^).A_#W_A6MAX/^#OB/2O#6L:=XALKQ]3\123V=
MI?WEQ;WL$_EV2Q6M]&(HWL[CSI8'5GA5]\?FGP:_X*2_$KQCXC^%/BS6=/\
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9** "BBB@ HHHH **** "BBB@ HHHH __V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139932124170064">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Document And Entity Information<br></strong></div></th>
<th class="th"><div>Apr. 13, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentInformationLineItems', window );"><strong>Document Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity, Registrant Name</a></td>
<td class="text">iCAD, INC.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document, Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document, Period End Date</a></td>
<td class="text">Apr. 13,  2023<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity, Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity, File Number</a></td>
<td class="text">001-09341<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity, Tax Identification Number</a></td>
<td class="text">02-0377419<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity, Address, Address Line One</a></td>
<td class="text">98 Spit Brook Road, Suite 100<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity, Address, City or Town</a></td>
<td class="text">Nashua<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity, Address, State or Province</a></td>
<td class="text">NH<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity, Address, Postal Zip Code</a></td>
<td class="text">03062<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">603<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">882-5200<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">ICAD<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity, Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity, Central Index Key</a></td>
<td class="text">0000749660<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>icad20230412_8k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2021q4"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="icad-20230413.xsd" xlink:type="simple"/>
    <context id="d20238K">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000749660</identifier>
        </entity>
        <period>
            <startDate>2023-04-13</startDate>
            <endDate>2023-04-13</endDate>
        </period>
    </context>
    <dei:AmendmentFlag contextRef="d20238K">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey contextRef="d20238K">0000749660</dei:EntityCentralIndexKey>
    <dei:DocumentType contextRef="d20238K">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="d20238K">2023-04-13</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="d20238K">iCAD, INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="d20238K">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="d20238K">001-09341</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="d20238K">02-0377419</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="d20238K">98 Spit Brook Road, Suite 100</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown contextRef="d20238K">Nashua</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="d20238K">NH</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="d20238K">03062</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="d20238K">603</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="d20238K">882-5200</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="d20238K">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="d20238K">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="d20238K">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="d20238K">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="d20238K">Common Stock</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="d20238K">ICAD</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="d20238K">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="d20238K">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>17
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M=]W3CHG&K=!X#;[Q3X?#KHG&J]!TZVDF)_VN:Z3I%FA"1N/K>A(5M>5 TR
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M!Z.:60F]A%9JGZJ'-#ZH'C(*!?&Y'C[E>G@*-Y;&O%"N@GL!_]':-\*K^(+
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MU4#E/]O4#6CV#30<D05>,9FV-J/D3@H\W/[O#;#"Q([A[8N_ 5!+ P04
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M(K1Z6^CY<6A4"H[<8R6,<6*T_C6"R0_L?@!02P,$%     @ QW.15CJJHN=
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MBBJ6<%H@XLD@;6E6?;!/3K3G>1<W]T6NS>,)KM\,<'AT_@%02P,$%     @
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MX3]>?P%02P$"% ,4    " #'<Y%6!T%-8H$   "Q    $
M@ $     9&]C4')O<',O87!P+GAM;%!+ 0(4 Q0    ( ,=SD58P6E^%[P
M "L"   1              "  :\   !D;V-0<F]P<R]C;W)E+GAM;%!+ 0(4
M Q0    ( ,=SD5:97)PC$ 8  )PG   3              "  <T!  !X;"]T
M:&5M92]T:&5M93$N>&UL4$L! A0#%     @ QW.15A;VVU8]!   E1   !@
M             ("!#@@  'AL+W=O<FMS:&5E=',O<VAE970Q+GAM;%!+ 0(4
M Q0    ( ,=SD5:?H!OPL0(  .(,   -              "  8$,  !X;"]S
M='EL97,N>&UL4$L! A0#%     @ QW.15I>*NQS     $P(   L
M     ( !70\  %]R96QS+RYR96QS4$L! A0#%     @ QW.15CJJHN=  0
M/ (   \              ( !1A   'AL+W=O<FMB;V]K+GAM;%!+ 0(4 Q0
M   ( ,=SD58D'INBK0   /@!   :              "  ;,1  !X;"]?<F5L
M<R]W;W)K8F]O:RYX;6PN<F5L<U!+ 0(4 Q0    ( ,=SD59ED'F2&0$  ,\#
M   3              "  9@2  !;0V]N=&5N=%]4>7!E<UTN>&UL4$L%!@
0   )  D /@(  .(3      $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.23.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>22</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="icad20230412_8k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>000 - Document - Document And Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.icad.com/20230413/role/statement-document-and-entity-information</Role>
      <ShortName>Document And Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" original="icad20230412_8k.htm">icad20230412_8k.htm</File>
    <File>ex_501441.htm</File>
    <File>ex_501442.htm</File>
    <File>icad-20230413.xsd</File>
    <File>icad-20230413_def.xml</File>
    <File>icad-20230413_lab.xml</File>
    <File>icad-20230413_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="22">http://xbrl.sec.gov/dei/2021q4</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>22
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "icad20230412_8k.htm": {
   "axisCustom": 0,
   "axisStandard": 0,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2021q4": 22
   },
   "contextCount": 1,
   "dts": {
    "definitionLink": {
     "local": [
      "icad-20230413_def.xml"
     ]
    },
    "inline": {
     "local": [
      "icad20230412_8k.htm"
     ]
    },
    "labelLink": {
     "local": [
      "icad-20230413_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "icad-20230413_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "icad-20230413.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd",
      "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.sec.gov/country/2021/country-2021.xsd",
      "https://xbrl.sec.gov/currency/2021/currency-2021.xsd",
      "https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd",
      "https://xbrl.sec.gov/exch/2021/exch-2021.xsd",
      "https://xbrl.sec.gov/sic/2021/sic-2021.xsd",
      "https://xbrl.sec.gov/stpr/2021/stpr-2021.xsd"
     ]
    }
   },
   "elementCount": 26,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2021q4": 2,
    "total": 2
   },
   "keyCustom": 0,
   "keyStandard": 22,
   "memberCustom": 0,
   "memberStandard": 0,
   "nsprefix": "icad",
   "nsuri": "http://www.icad.com/20230413",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "icad20230412_8k.htm",
      "contextRef": "d20238K",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:EntityRegistrantName",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "000 - Document - Document And Entity Information",
     "menuCat": "Cover",
     "order": "1",
     "role": "http://www.icad.com/20230413/role/statement-document-and-entity-information",
     "shortName": "Document And Entity Information",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "icad20230412_8k.htm",
      "contextRef": "d20238K",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:EntityRegistrantName",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 0,
   "tag": {
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.icad.com/20230413/role/statement-document-and-entity-information"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.icad.com/20230413/role/statement-document-and-entity-information"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_DocumentInformationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Document Information [Line Items]"
       }
      }
     },
     "localname": "DocumentInformationLineItems",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.icad.com/20230413/role/statement-document-and-entity-information"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_DocumentInformationTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Container to support the formal attachment of each official or unofficial, public or private document as part of a submission package.",
        "label": "Document Information [Table]"
       }
      }
     },
     "localname": "DocumentInformationTable",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "xbrltype": "stringItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document, Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.icad.com/20230413/role/statement-document-and-entity-information"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document, Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.icad.com/20230413/role/statement-document-and-entity-information"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity, Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.icad.com/20230413/role/statement-document-and-entity-information"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity, Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.icad.com/20230413/role/statement-document-and-entity-information"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity, Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.icad.com/20230413/role/statement-document-and-entity-information"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity, Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.icad.com/20230413/role/statement-document-and-entity-information"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity, Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.icad.com/20230413/role/statement-document-and-entity-information"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains.",
        "label": "Entity [Domain]"
       }
      }
     },
     "localname": "EntityDomain",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.icad.com/20230413/role/statement-document-and-entity-information"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity, Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.icad.com/20230413/role/statement-document-and-entity-information"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity, File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.icad.com/20230413/role/statement-document-and-entity-information"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity, Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.icad.com/20230413/role/statement-document-and-entity-information"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity, Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.icad.com/20230413/role/statement-document-and-entity-information"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity, Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.icad.com/20230413/role/statement-document-and-entity-information"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LegalEntityAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The set of legal entities associated with a report.",
        "label": "Legal Entity [Axis]"
       }
      }
     },
     "localname": "LegalEntityAxis",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.icad.com/20230413/role/statement-document-and-entity-information"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.icad.com/20230413/role/statement-document-and-entity-information"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "auth_ref": [
      "r3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
        "label": "Pre-commencement Issuer Tender Offer"
       }
      }
     },
     "localname": "PreCommencementIssuerTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.icad.com/20230413/role/statement-document-and-entity-information"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementTenderOffer": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
        "label": "Pre-commencement Tender Offer"
       }
      }
     },
     "localname": "PreCommencementTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.icad.com/20230413/role/statement-document-and-entity-information"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.icad.com/20230413/role/statement-document-and-entity-information"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.icad.com/20230413/role/statement-document-and-entity-information"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_SolicitingMaterial": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
        "label": "Soliciting Material"
       }
      }
     },
     "localname": "SolicitingMaterial",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.icad.com/20230413/role/statement-document-and-entity-information"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.icad.com/20230413/role/statement-document-and-entity-information"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dei_WrittenCommunications": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
        "label": "Written Communications"
       }
      }
     },
     "localname": "WrittenCommunications",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.icad.com/20230413/role/statement-document-and-entity-information"
     ],
     "xbrltype": "booleanItemType"
    }
   },
   "unitCount": 0
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r1": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r2": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r3": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13e",
   "Subsection": "4c",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r4": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14d",
   "Subsection": "2b",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r5": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14a",
   "Subsection": "12",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r6": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "425",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  }
 },
 "version": "2.2"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>23
<FILENAME>0001437749-23-010408-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001437749-23-010408-xbrl.zip
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M/C('?F@D_37%G?B;X/57,A'*A,<9ZA1'QZ;,JSJ8VE^3,CE5H3#)5#)G*!G
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M).[XW?I^M^>P1P>]5CSN37Q==]]T[P\]M.#G1TXWXW-H0>G]XI#.P.X/K/S
M0M(71@&HU!?GG+!7ZK/P6':%K?Y<6#8/ 4&(]VZ#DF<II]:#)0ABX4^WX)?-
M5+C(SQV1Q,<FZ<EV/CTU-7/(^4&X 5PA:.%J36GW++0[5;"XIP(BDMJXL=]/
M(9S&M61];6=];7<=+Q5:=GCE$WB&FV2 GF[2 [:??O=B>Q,_VHBV$3I2PRH+
MO0)KN;FW2I/2I>DWHY->;,L!%3YV)K/*:#.:< Z"EV<J1>E9^:7>F5]Y;8[#
M<=S5[([HXQ3BD/1[Z0!]PE%LB;J&S3<6=6+JY8N#.NVK)<Q!\]:%KM>K,]W-
M'R%D_"+!!%]CSRZ8[#!67B07K%#;O B@ A;WDH3D 1(1Z+7=^AH+? WNAE[4
MRL[>4_Z'CXE)@%JIC,?DZF@_*[<>2P/CR'C$[*_)W:JR8,"F'!P\ASJ#D@.
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M=.88@VW>9"^IS2G:TM02CDC!:\'(A&F2%U@-<M-+6S)@%X<]^ZII0=)*IS^
M"#>^O;_.^;BP'_7+' =</\GW' 2Z-[@5GS[BH>5[NV_BZ*!,;\+*&8SE^V?1
M,5H&1Z_KJGI/STA(C(Z[G';+]M;6S8]/NK/%_("?D^F,''WR(K<>;3W=N?G!
M[;8M?;VW_W:5+_NH?-EW-Y0O^VZ5+UOERSX]O/HE3:)!3T(FX3LE>Z/LM84:
M>]MCV"PL!*RI#['$D+(_M>:1K0^0+P?]!V,'2_X$.Z</E$]:9Z+8 0J[/%K.
M>Z &VU>X>5M7-&4"LZ$5[-&[2=;, 1\O,Z7$@RMI<2\#K>(3G@4U"+GH?0"G
MTGO:K(,WTX(17&ZIZ6">P&:]QECP(P9&-3S[WXCY)C[<SF4^G$<$[9<M#  ?
M7G@8]9E!&#08(O-H65XKI.:**!MH !&W=57N@MSU^5S%A:5%U71*LX],<-G'
MT$5\4G&TA#U]3T#8QR+V$F%F.JJR7+N.&GE)?T>! Y("<96]X6UM!!V;#$%:
M#!^=9X-27@N2IVT%7*UN1P':S8 6!Q"*0=3\RE4MW;=M$T\WDF9^*(TF82#,
MESR, QQ<1RU331X*C1%<49(*/4]J<"E>Q Z&Q%%!-P4:_'B?,XX1(2/\OBDN
M^BF'A<$G"8C$FE/NU.=T<5)ZI."Q&*LK.8)80T[\$(YJ-K;)K01?F@71%*9C
ME6NK\0*^CEZAHB#*;*1J5B2:7@NPF#/DWRXDHRM,MQK?&D+/+>IUF%BS73XX
M!;*0!\OFJQWJ+*0Z[K<@D>XC%DCGHU"]X+,+\N%&?I@<8EM4]BYA9\'JS@.M
M!Q6@O"=IY'@J4L]<!I/1I66_^.71VHXK.MK7W1L=F=:VG#Z06GVZO$,C9D_!
M^-WCD-5A/5Y<"A +D4$\QT1J4_(\-N[\7,W#"%:A[3G=;[L"7.L$^)7CPFE0
MTK2+Y5I<A.PWY%6;UZ:T;-B9M8^R>W JC59Q3AUZ/#;2B%R#$JKBU5+/+?6E
MC$O#I?X]X7(B7KL]M;*_P!*?X[89'P>V4[W--6? Q'.E()NL7*FD'+_QG!AD
M5=K-28$]D"]ZY0-M6.9L#7 ]*>I@T')*<O]L?O=PC(O3"%7MP?J^#G?^UT.K
M(&@W,3^,^;GS<#CE&%9=MQGMHZ;_JB%["G.>1$5%V9(9H01@@K( 9VC19&,'
M$D+'*U+/["<-$Y^]UU=62]@D<X-:;<JY3?D13%2T*W<;Q-,A% OWHA[I[ P'
M%1*+Z*5X0ZKAD/!=U1L,4LRA50NV<0'MY8%Q:H5-#_S*_W:UU'-+_?1Z;I9Z
M3',+C!"(,^*;H17?.#,^-XTWY(-2#-?M85F2>)2+?U,M=&W\EJ?=79N!9K42
MH%J. 6Y=BC1M5=OJ5UN6)^+&BHY)24)9@Q(&1=CI90/M&;HI)[*%R4^!%'5/
M^K5B,)E6ZO/W7RS6\BP,L!%;DD^/"_\\E*W6F64OH5'5V88,6MX^]4"V:V=X
M5\Q-GQC ?G9# >QGJP#V-QW 7JC2/ZJT]B<)F9(6^B4YCQY&_SL$.3XDEUC
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MA?4<6.VB$Y-,8ZURD?(P33D&-/1:[F/*"4-G7*VADCXZ:'4S26HSJ0KH4&Z
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MI'),*$V_]H@-!LL2*ED(>:(M;"DN-B,?G.8K7>9\6+6DC&S-S#"X)]9:0,Z
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M5N3^RZ568K9]J)J%U-=5!U'9()EA(9'J9,F9V1)G*4U6- B>>$IBD9#G<JJ
MCUA$T<(^DI+.'*@Y%ELP-MFN4 Q%@4TZ):.TRI1_^$)P$0&.CBY$+(?YPC,R
MN>1(&1N3(1VVDMUO0'9)6KF[PN@BZ@,H%0AG/B0(M>.3V,7^@*6KR)!)I*CD
M%*Q=0='1>V-F3GO:=(@V5VOP8W$J,RDVD0"_\N!R&+A*5B"[;T+XI")7VO&
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MYHC+64(F%4UC?@;2GO9B,_K=,&(?G EYRQ6$4F=*+ED)ODW#SICAVQJ^%0>
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MTPO9-OUV@*Y/R&\EF^+'+<.ECTW:80QJ?>U_D&8C>"C-+S='Z\%T3]&/MU0
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MC?:\$JX'.\XLN6ADI;4@0>C+%]2"N%C<@).589[BAW)7@1H __H,9<;1C[X
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MEC%M)>?X!M%NLA<Y+G$V.,UHE"/)")Y+WUC=?"A+F*?LKID:#@E]*-$8.E\
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MV23.U=T=%KF)6P$PI\,66)R$-9@,7"50(67-#08^KD'V6>QA<%N#OF_K;-)
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MXF_5.'</03\,\WA)[SVM9NF[_P%02P,$%     @ QW.15F&S9C3+$0  4S\
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M7YKO&-!^^^B %TCS.,+&=,$OR1CCK07NBB?1;\LPFSLNI4CONI0Z\KD>8BP
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MF,5+(G5V&W!996HSK'6RKK_X^0U02P,$%     @ QW.15LW:_C#=!   42T
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MC:;ZU2$6%J"-L/I5(D7VH8VJ^E4>MI:CC;KZ%2'G&90V&NM7B)CM31M-]2M
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M_=GB8>U+=,36]=M')/L_6/')?U!+ P04    " #'<Y%6UXDW#W<$  #E+0
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MGFG)>/QBQ*KK_!A/.<2-!7\.$Z"J_^B?CCH-]J=:#KS\^UYWBJ%/Z*D[1F;
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M4$L! A0#%     @ QW.15F&S9C3+$0  4S\   T              ( !F7H
M &5X7S4P,30T,BYH=&U02P$"% ,4    " #'<Y%6W$+DIWH#   O#@  $0
M            @ &/C   :6-A9"TR,#(S,#0Q,RYX<V102P$"% ,4    " #'
M<Y%6S=K^,-T$  !1+0  %0              @ $XD   :6-A9"TR,#(S,#0Q
M,U]D968N>&UL4$L! A0#%     @ QW.15JW,T:3\!0  JSP  !4
M     ( !2)4  &EC860M,C R,S T,3-?;&%B+GAM;%!+ 0(4 Q0    ( ,=S
MD5;7B3</=P0  .4M   5              "  7>;  !I8V%D+3(P,C,P-#$S
M7W!R92YX;6Q02P$"% ,4    " #'<Y%6V>S6?$83  #%A@  $P
M    @ $AH   :6-A9#(P,C,P-#$R7SAK+FAT;5!+!08     !P ' +\!  "8
%LP     !

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
